CN104363756B - 含有二肽衍生物作为活性成分的农业植物‑保护剂 - Google Patents
含有二肽衍生物作为活性成分的农业植物‑保护剂 Download PDFInfo
- Publication number
- CN104363756B CN104363756B CN201380028197.3A CN201380028197A CN104363756B CN 104363756 B CN104363756 B CN 104363756B CN 201380028197 A CN201380028197 A CN 201380028197A CN 104363756 B CN104363756 B CN 104363756B
- Authority
- CN
- China
- Prior art keywords
- compound
- nmr
- plant
- cdcl
- 400mhz
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 102000004860 Dipeptidases Human genes 0.000 title claims abstract description 33
- 108090001081 Dipeptidases Proteins 0.000 title claims abstract description 33
- 241001597008 Nomeidae Species 0.000 title claims abstract description 33
- 239000011814 protection agent Substances 0.000 title abstract description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 40
- 201000010099 disease Diseases 0.000 claims abstract description 37
- 150000003839 salts Chemical class 0.000 claims abstract description 29
- 239000000575 pesticide Substances 0.000 claims abstract description 13
- 230000003213 activating effect Effects 0.000 claims abstract 2
- 241000196324 Embryophyta Species 0.000 claims description 141
- 150000001875 compounds Chemical class 0.000 claims description 110
- -1 t- butoxy Chemical group 0.000 claims description 97
- 239000007788 liquid Substances 0.000 claims description 62
- 239000003223 protective agent Substances 0.000 claims description 32
- 239000000126 substance Substances 0.000 claims description 31
- 240000008574 Capsicum frutescens Species 0.000 claims description 28
- 235000002566 Capsicum Nutrition 0.000 claims description 22
- 241000233614 Phytophthora Species 0.000 claims description 20
- 239000001390 capsicum minimum Substances 0.000 claims description 20
- 238000002360 preparation method Methods 0.000 claims description 19
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 claims description 17
- 230000001580 bacterial effect Effects 0.000 claims description 16
- 244000061176 Nicotiana tabacum Species 0.000 claims description 14
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 14
- 240000008067 Cucumis sativus Species 0.000 claims description 13
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 claims description 13
- 239000003795 chemical substances by application Substances 0.000 claims description 12
- 229940017219 methyl propionate Drugs 0.000 claims description 11
- 239000000843 powder Substances 0.000 claims description 11
- RJUFJBKOKNCXHH-UHFFFAOYSA-N Methyl propionate Chemical compound CCC(=O)OC RJUFJBKOKNCXHH-UHFFFAOYSA-N 0.000 claims description 10
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 239000008187 granular material Substances 0.000 claims description 8
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 7
- 244000061456 Solanum tuberosum Species 0.000 claims description 7
- 241001233957 eudicotyledons Species 0.000 claims description 7
- 241000234282 Allium Species 0.000 claims description 6
- 235000002732 Allium cepa var. cepa Nutrition 0.000 claims description 6
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims description 6
- 240000003768 Solanum lycopersicum Species 0.000 claims description 6
- 239000003814 drug Substances 0.000 claims description 6
- 235000010149 Brassica rapa subsp chinensis Nutrition 0.000 claims description 5
- 235000000536 Brassica rapa subsp pekinensis Nutrition 0.000 claims description 5
- 241000499436 Brassica rapa subsp. pekinensis Species 0.000 claims description 5
- 235000016623 Fragaria vesca Nutrition 0.000 claims description 5
- 240000009088 Fragaria x ananassa Species 0.000 claims description 5
- 235000011363 Fragaria x ananassa Nutrition 0.000 claims description 5
- 235000004279 alanine Nutrition 0.000 claims description 5
- 230000002265 prevention Effects 0.000 claims description 5
- 240000007124 Brassica oleracea Species 0.000 claims description 4
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 claims description 4
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 claims description 4
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 claims description 4
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 claims description 4
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 4
- 240000005979 Hordeum vulgare Species 0.000 claims description 4
- 240000007594 Oryza sativa Species 0.000 claims description 4
- 235000007164 Oryza sativa Nutrition 0.000 claims description 4
- 244000088415 Raphanus sativus Species 0.000 claims description 4
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 claims description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 4
- 235000009566 rice Nutrition 0.000 claims description 4
- 239000000725 suspension Substances 0.000 claims description 4
- 240000002234 Allium sativum Species 0.000 claims description 3
- 244000144730 Amygdalus persica Species 0.000 claims description 3
- 240000007087 Apium graveolens Species 0.000 claims description 3
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 claims description 3
- 235000010591 Appio Nutrition 0.000 claims description 3
- 235000017060 Arachis glabrata Nutrition 0.000 claims description 3
- 244000105624 Arachis hypogaea Species 0.000 claims description 3
- 235000010777 Arachis hypogaea Nutrition 0.000 claims description 3
- 235000018262 Arachis monticola Nutrition 0.000 claims description 3
- 240000004160 Capsicum annuum Species 0.000 claims description 3
- 244000241235 Citrullus lanatus Species 0.000 claims description 3
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 claims description 3
- 235000011511 Diospyros Nutrition 0.000 claims description 3
- 244000236655 Diospyros kaki Species 0.000 claims description 3
- 235000003228 Lactuca sativa Nutrition 0.000 claims description 3
- 240000008415 Lactuca sativa Species 0.000 claims description 3
- 235000011430 Malus pumila Nutrition 0.000 claims description 3
- 235000015103 Malus silvestris Nutrition 0.000 claims description 3
- 240000004371 Panax ginseng Species 0.000 claims description 3
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 3
- 235000004347 Perilla Nutrition 0.000 claims description 3
- 244000124853 Perilla frutescens Species 0.000 claims description 3
- 235000006040 Prunus persica var persica Nutrition 0.000 claims description 3
- 235000014443 Pyrus communis Nutrition 0.000 claims description 3
- 240000001987 Pyrus communis Species 0.000 claims description 3
- 240000003829 Sorghum propinquum Species 0.000 claims description 3
- 235000011684 Sorghum saccharatum Nutrition 0.000 claims description 3
- 240000008042 Zea mays Species 0.000 claims description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 3
- 244000273928 Zingiber officinale Species 0.000 claims description 3
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 3
- 235000005822 corn Nutrition 0.000 claims description 3
- 235000004611 garlic Nutrition 0.000 claims description 3
- 235000008397 ginger Nutrition 0.000 claims description 3
- 235000008434 ginseng Nutrition 0.000 claims description 3
- 235000020232 peanut Nutrition 0.000 claims description 3
- 230000009182 swimming Effects 0.000 claims description 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 2
- 239000004495 emulsifiable concentrate Substances 0.000 claims description 2
- 206010003694 Atrophy Diseases 0.000 claims 1
- 244000241257 Cucumis melo Species 0.000 claims 1
- 235000009847 Cucumis melo var cantalupensis Nutrition 0.000 claims 1
- 244000081841 Malus domestica Species 0.000 claims 1
- 230000037444 atrophy Effects 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 57
- 230000008635 plant growth Effects 0.000 abstract description 9
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 256
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 136
- 238000005160 1H NMR spectroscopy Methods 0.000 description 107
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 99
- 239000007787 solid Substances 0.000 description 49
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 44
- 238000012545 processing Methods 0.000 description 33
- 241000233616 Phytophthora capsici Species 0.000 description 26
- 238000000034 method Methods 0.000 description 23
- 150000003235 pyrrolidines Chemical class 0.000 description 22
- 239000002585 base Substances 0.000 description 18
- 230000006378 damage Effects 0.000 description 18
- 244000052769 pathogen Species 0.000 description 18
- 230000001717 pathogenic effect Effects 0.000 description 18
- 230000014509 gene expression Effects 0.000 description 17
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical class OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 13
- 230000015572 biosynthetic process Effects 0.000 description 13
- 230000012010 growth Effects 0.000 description 13
- 239000000243 solution Substances 0.000 description 13
- 238000012360 testing method Methods 0.000 description 13
- 101000742121 Arabidopsis thaliana Pathogenesis-related protein 1 Proteins 0.000 description 12
- 101000742139 Cucumis melo Pathogenesis-related protein Proteins 0.000 description 12
- 108010016626 Dipeptides Proteins 0.000 description 12
- 208000035240 Disease Resistance Diseases 0.000 description 12
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 12
- 241000894006 Bacteria Species 0.000 description 10
- 241000606012 Pectinatus Species 0.000 description 10
- 108090000623 proteins and genes Proteins 0.000 description 10
- 244000000626 Daucus carota Species 0.000 description 9
- 235000002767 Daucus carota Nutrition 0.000 description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 241000531155 Pectobacterium Species 0.000 description 9
- 239000007921 spray Substances 0.000 description 9
- 238000003786 synthesis reaction Methods 0.000 description 9
- STPKWKPURVSAJF-LJEWAXOPSA-N (4r,5r)-5-[4-[[4-(1-aza-4-azoniabicyclo[2.2.2]octan-4-ylmethyl)phenyl]methoxy]phenyl]-3,3-dibutyl-7-(dimethylamino)-1,1-dioxo-4,5-dihydro-2h-1$l^{6}-benzothiepin-4-ol Chemical compound O[C@H]1C(CCCC)(CCCC)CS(=O)(=O)C2=CC=C(N(C)C)C=C2[C@H]1C(C=C1)=CC=C1OCC(C=C1)=CC=C1C[N+]1(CC2)CCN2CC1 STPKWKPURVSAJF-LJEWAXOPSA-N 0.000 description 8
- 230000006698 induction Effects 0.000 description 8
- 230000019491 signal transduction Effects 0.000 description 8
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 7
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 7
- 239000002253 acid Substances 0.000 description 7
- 125000003368 amide group Chemical group 0.000 description 7
- 235000001014 amino acid Nutrition 0.000 description 7
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 7
- 239000004094 surface-active agent Substances 0.000 description 7
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N monobenzene Natural products C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- 229910052757 nitrogen Inorganic materials 0.000 description 6
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 6
- 108090000765 processed proteins & peptides Proteins 0.000 description 6
- 229960004889 salicylic acid Drugs 0.000 description 6
- QXOGPTXQGKQSJT-UHFFFAOYSA-N 1-amino-4-[4-(3,4-dimethylphenyl)sulfanylanilino]-9,10-dioxoanthracene-2-sulfonic acid Chemical compound Cc1ccc(Sc2ccc(Nc3cc(c(N)c4C(=O)c5ccccc5C(=O)c34)S(O)(=O)=O)cc2)cc1C QXOGPTXQGKQSJT-UHFFFAOYSA-N 0.000 description 5
- 101100063004 Arabidopsis thaliana PDF1.2A gene Proteins 0.000 description 5
- 108010022172 Chitinases Proteins 0.000 description 5
- 102000012286 Chitinases Human genes 0.000 description 5
- 108010002069 Defensins Proteins 0.000 description 5
- 102000003992 Peroxidases Human genes 0.000 description 5
- 101100084161 Phaseolus vulgaris PR4 gene Proteins 0.000 description 5
- 101000900567 Pisum sativum Disease resistance response protein Pi49 Proteins 0.000 description 5
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 125000000217 alkyl group Chemical group 0.000 description 5
- 230000001939 inductive effect Effects 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 208000014674 injury Diseases 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 108040007629 peroxidase activity proteins Proteins 0.000 description 5
- HSHNITRMYYLLCV-UHFFFAOYSA-N 4-methylumbelliferone Chemical compound C1=C(O)C=CC2=C1OC(=O)C=C2C HSHNITRMYYLLCV-UHFFFAOYSA-N 0.000 description 4
- 241000219193 Brassicaceae Species 0.000 description 4
- 241000219112 Cucumis Species 0.000 description 4
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 4
- 108010001682 Dextranase Proteins 0.000 description 4
- 241000208292 Solanaceae Species 0.000 description 4
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 4
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 230000007123 defense Effects 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N dichloromethane Substances ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 235000019439 ethyl acetate Nutrition 0.000 description 4
- FKRCODPIKNYEAC-UHFFFAOYSA-N ethyl propionate Chemical compound CCOC(=O)CC FKRCODPIKNYEAC-UHFFFAOYSA-N 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical class CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 4
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 4
- 239000000376 reactant Substances 0.000 description 4
- 230000001629 suppression Effects 0.000 description 4
- 238000010189 synthetic method Methods 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- HUWSZNZAROKDRZ-RRLWZMAJSA-N (3r,4r)-3-azaniumyl-5-[[(2s,3r)-1-[(2s)-2,3-dicarboxypyrrolidin-1-yl]-3-methyl-1-oxopentan-2-yl]amino]-5-oxo-4-sulfanylpentane-1-sulfonate Chemical compound OS(=O)(=O)CC[C@@H](N)[C@@H](S)C(=O)N[C@@H]([C@H](C)CC)C(=O)N1CCC(C(O)=O)[C@H]1C(O)=O HUWSZNZAROKDRZ-RRLWZMAJSA-N 0.000 description 3
- ONBQEOIKXPHGMB-VBSBHUPXSA-N 1-[2-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)propan-1-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 ONBQEOIKXPHGMB-VBSBHUPXSA-N 0.000 description 3
- QGLVWTFUWVTDEQ-UHFFFAOYSA-N 2-chloro-3-methoxyphenol Chemical compound COC1=CC=CC(O)=C1Cl QGLVWTFUWVTDEQ-UHFFFAOYSA-N 0.000 description 3
- JSDZSLGMRRSAHD-UHFFFAOYSA-N 3-methylbutan-2-ylcyclopropane Chemical compound CC(C)C(C)C1CC1 JSDZSLGMRRSAHD-UHFFFAOYSA-N 0.000 description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 3
- 102100029952 Double-strand-break repair protein rad21 homolog Human genes 0.000 description 3
- 101000584942 Homo sapiens Double-strand-break repair protein rad21 homolog Proteins 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- LVDRREOUMKACNJ-BKMJKUGQSA-N N-[(2R,3S)-2-(4-chlorophenyl)-1-(1,4-dimethyl-2-oxoquinolin-7-yl)-6-oxopiperidin-3-yl]-2-methylpropane-1-sulfonamide Chemical compound CC(C)CS(=O)(=O)N[C@H]1CCC(=O)N([C@@H]1c1ccc(Cl)cc1)c1ccc2c(C)cc(=O)n(C)c2c1 LVDRREOUMKACNJ-BKMJKUGQSA-N 0.000 description 3
- 244000046052 Phaseolus vulgaris Species 0.000 description 3
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 208000010399 Wasting Syndrome Diseases 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 239000003899 bactericide agent Substances 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229940125898 compound 5 Drugs 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 230000006353 environmental stress Effects 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 235000019253 formic acid Nutrition 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 description 3
- 239000002689 soil Substances 0.000 description 3
- ASGMFNBUXDJWJJ-JLCFBVMHSA-N (1R,3R)-3-[[3-bromo-1-[4-(5-methyl-1,3,4-thiadiazol-2-yl)phenyl]pyrazolo[3,4-d]pyrimidin-6-yl]amino]-N,1-dimethylcyclopentane-1-carboxamide Chemical compound BrC1=NN(C2=NC(=NC=C21)N[C@H]1C[C@@](CC1)(C(=O)NC)C)C1=CC=C(C=C1)C=1SC(=NN=1)C ASGMFNBUXDJWJJ-JLCFBVMHSA-N 0.000 description 2
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 description 2
- IUSARDYWEPUTPN-OZBXUNDUSA-N (2r)-n-[(2s,3r)-4-[[(4s)-6-(2,2-dimethylpropyl)spiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-3-hydroxy-1-[3-(1,3-thiazol-2-yl)phenyl]butan-2-yl]-2-methoxypropanamide Chemical compound C([C@H](NC(=O)[C@@H](C)OC)[C@H](O)CN[C@@H]1C2=CC(CC(C)(C)C)=CN=C2OC2(CCC2)C1)C(C=1)=CC=CC=1C1=NC=CS1 IUSARDYWEPUTPN-OZBXUNDUSA-N 0.000 description 2
- VIJSPAIQWVPKQZ-BLECARSGSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-acetamido-5-(diaminomethylideneamino)pentanoyl]amino]-4-methylpentanoyl]amino]-4,4-dimethylpentanoyl]amino]-4-methylpentanoyl]amino]propanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound NC(=N)NCCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(C)=O VIJSPAIQWVPKQZ-BLECARSGSA-N 0.000 description 2
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 description 2
- FMKGJQHNYMWDFJ-CVEARBPZSA-N 2-[[4-(2,2-difluoropropoxy)pyrimidin-5-yl]methylamino]-4-[[(1R,4S)-4-hydroxy-3,3-dimethylcyclohexyl]amino]pyrimidine-5-carbonitrile Chemical compound FC(COC1=NC=NC=C1CNC1=NC=C(C(=N1)N[C@H]1CC([C@H](CC1)O)(C)C)C#N)(C)F FMKGJQHNYMWDFJ-CVEARBPZSA-N 0.000 description 2
- TVTJUIAKQFIXCE-HUKYDQBMSA-N 2-amino-9-[(2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-prop-2-ynyl-1H-purine-6,8-dione Chemical compound NC=1NC(C=2N(C(N(C=2N=1)[C@@H]1O[C@@H]([C@H]([C@H]1O)F)CO)=O)CC#C)=O TVTJUIAKQFIXCE-HUKYDQBMSA-N 0.000 description 2
- 125000005977 3-phenylpropyloxy group Chemical group 0.000 description 2
- DQAZPZIYEOGZAF-UHFFFAOYSA-N 4-ethyl-n-[4-(3-ethynylanilino)-7-methoxyquinazolin-6-yl]piperazine-1-carboxamide Chemical compound C1CN(CC)CCN1C(=O)NC(C(=CC1=NC=N2)OC)=CC1=C2NC1=CC=CC(C#C)=C1 DQAZPZIYEOGZAF-UHFFFAOYSA-N 0.000 description 2
- 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- RSIWALKZYXPAGW-NSHDSACASA-N 6-(3-fluorophenyl)-3-methyl-7-[(1s)-1-(7h-purin-6-ylamino)ethyl]-[1,3]thiazolo[3,2-a]pyrimidin-5-one Chemical compound C=1([C@@H](NC=2C=3N=CNC=3N=CN=2)C)N=C2SC=C(C)N2C(=O)C=1C1=CC=CC(F)=C1 RSIWALKZYXPAGW-NSHDSACASA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000193738 Bacillus anthracis Species 0.000 description 2
- 241000208293 Capsicum Species 0.000 description 2
- 240000008384 Capsicum annuum var. annuum Species 0.000 description 2
- 241000222235 Colletotrichum orbiculare Species 0.000 description 2
- 229940127007 Compound 39 Drugs 0.000 description 2
- 241000219104 Cucurbitaceae Species 0.000 description 2
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- 244000070406 Malus silvestris Species 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- 239000006002 Pepper Substances 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 235000016761 Piper aduncum Nutrition 0.000 description 2
- 240000003889 Piper guineense Species 0.000 description 2
- 235000017804 Piper guineense Nutrition 0.000 description 2
- 235000008184 Piper nigrum Nutrition 0.000 description 2
- 241000209504 Poaceae Species 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 108010006785 Taq Polymerase Proteins 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- IOSLINNLJFQMFF-XMMPIXPASA-N [(2R)-1-[[4-[[3-[(4-fluorophenyl)methylsulfanyl]phenoxy]methyl]phenyl]methyl]pyrrolidin-2-yl]methanol Chemical compound FC1=CC=C(CSC=2C=C(OCC3=CC=C(CN4[C@H](CCC4)CO)C=C3)C=CC=2)C=C1 IOSLINNLJFQMFF-XMMPIXPASA-N 0.000 description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 125000005907 alkyl ester group Chemical group 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 239000008122 artificial sweetener Substances 0.000 description 2
- XRWSZZJLZRKHHD-WVWIJVSJSA-N asunaprevir Chemical compound O=C([C@@H]1C[C@H](CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)OC1=NC=C(C2=CC=C(Cl)C=C21)OC)N[C@]1(C(=O)NS(=O)(=O)C2CC2)C[C@H]1C=C XRWSZZJLZRKHHD-WVWIJVSJSA-N 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000004927 clay Substances 0.000 description 2
- 229940125797 compound 12 Drugs 0.000 description 2
- 229940126142 compound 16 Drugs 0.000 description 2
- 229940125810 compound 20 Drugs 0.000 description 2
- 229940125961 compound 24 Drugs 0.000 description 2
- 229940125851 compound 27 Drugs 0.000 description 2
- 229940125807 compound 37 Drugs 0.000 description 2
- 229940127113 compound 57 Drugs 0.000 description 2
- 229940125900 compound 59 Drugs 0.000 description 2
- 238000006482 condensation reaction Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- JAXFJECJQZDFJS-XHEPKHHKSA-N gtpl8555 Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N[C@H](B1O[C@@]2(C)[C@H]3C[C@H](C3(C)C)C[C@H]2O1)CCC1=CC=C(F)C=C1 JAXFJECJQZDFJS-XHEPKHHKSA-N 0.000 description 2
- 101150054900 gus gene Proteins 0.000 description 2
- 230000002363 herbicidal effect Effects 0.000 description 2
- 239000004009 herbicide Substances 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 230000005934 immune activation Effects 0.000 description 2
- 125000000814 indol-3-yl group Chemical group [H]C1=C([H])C([H])=C2N([H])C([H])=C([*])C2=C1[H] 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 239000002917 insecticide Substances 0.000 description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 150000007530 organic bases Chemical class 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- BXRNXXXXHLBUKK-UHFFFAOYSA-N piperazine-2,5-dione Chemical class O=C1CNC(=O)CN1 BXRNXXXXHLBUKK-UHFFFAOYSA-N 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 239000001294 propane Substances 0.000 description 2
- 235000019260 propionic acid Nutrition 0.000 description 2
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000008261 resistance mechanism Effects 0.000 description 2
- 229910052814 silicon oxide Inorganic materials 0.000 description 2
- 235000017550 sodium carbonate Nutrition 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 238000013268 sustained release Methods 0.000 description 2
- 239000012730 sustained-release form Substances 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 2
- 125000003774 valeryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- UAOUIVVJBYDFKD-XKCDOFEDSA-N (1R,9R,10S,11R,12R,15S,18S,21R)-10,11,21-trihydroxy-8,8-dimethyl-14-methylidene-4-(prop-2-enylamino)-20-oxa-5-thia-3-azahexacyclo[9.7.2.112,15.01,9.02,6.012,18]henicosa-2(6),3-dien-13-one Chemical compound C([C@@H]1[C@@H](O)[C@@]23C(C1=C)=O)C[C@H]2[C@]12C(N=C(NCC=C)S4)=C4CC(C)(C)[C@H]1[C@H](O)[C@]3(O)OC2 UAOUIVVJBYDFKD-XKCDOFEDSA-N 0.000 description 1
- AOSZTAHDEDLTLQ-AZKQZHLXSA-N (1S,2S,4R,8S,9S,11S,12R,13S,19S)-6-[(3-chlorophenyl)methyl]-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one Chemical compound C([C@@H]1C[C@H]2[C@H]3[C@]([C@]4(C=CC(=O)C=C4[C@@H](F)C3)C)(F)[C@@H](O)C[C@@]2([C@@]1(C1)C(=O)CO)C)N1CC1=CC=CC(Cl)=C1 AOSZTAHDEDLTLQ-AZKQZHLXSA-N 0.000 description 1
- ABJSOROVZZKJGI-OCYUSGCXSA-N (1r,2r,4r)-2-(4-bromophenyl)-n-[(4-chlorophenyl)-(2-fluoropyridin-4-yl)methyl]-4-morpholin-4-ylcyclohexane-1-carboxamide Chemical compound C1=NC(F)=CC(C(NC(=O)[C@H]2[C@@H](C[C@@H](CC2)N2CCOCC2)C=2C=CC(Br)=CC=2)C=2C=CC(Cl)=CC=2)=C1 ABJSOROVZZKJGI-OCYUSGCXSA-N 0.000 description 1
- GLGNXYJARSMNGJ-VKTIVEEGSA-N (1s,2s,3r,4r)-3-[[5-chloro-2-[(1-ethyl-6-methoxy-2-oxo-4,5-dihydro-3h-1-benzazepin-7-yl)amino]pyrimidin-4-yl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide Chemical compound CCN1C(=O)CCCC2=C(OC)C(NC=3N=C(C(=CN=3)Cl)N[C@H]3[C@H]([C@@]4([H])C[C@@]3(C=C4)[H])C(N)=O)=CC=C21 GLGNXYJARSMNGJ-VKTIVEEGSA-N 0.000 description 1
- SZUVGFMDDVSKSI-WIFOCOSTSA-N (1s,2s,3s,5r)-1-(carboxymethyl)-3,5-bis[(4-phenoxyphenyl)methyl-propylcarbamoyl]cyclopentane-1,2-dicarboxylic acid Chemical compound O=C([C@@H]1[C@@H]([C@](CC(O)=O)([C@H](C(=O)N(CCC)CC=2C=CC(OC=3C=CC=CC=3)=CC=2)C1)C(O)=O)C(O)=O)N(CCC)CC(C=C1)=CC=C1OC1=CC=CC=C1 SZUVGFMDDVSKSI-WIFOCOSTSA-N 0.000 description 1
- YJLIKUSWRSEPSM-WGQQHEPDSA-N (2r,3r,4s,5r)-2-[6-amino-8-[(4-phenylphenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound C=1C=C(C=2C=CC=CC=2)C=CC=1CNC1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O YJLIKUSWRSEPSM-WGQQHEPDSA-N 0.000 description 1
- WWTBZEKOSBFBEM-SPWPXUSOSA-N (2s)-2-[[2-benzyl-3-[hydroxy-[(1r)-2-phenyl-1-(phenylmethoxycarbonylamino)ethyl]phosphoryl]propanoyl]amino]-3-(1h-indol-3-yl)propanoic acid Chemical compound N([C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)O)C(=O)C(CP(O)(=O)[C@H](CC=1C=CC=CC=1)NC(=O)OCC=1C=CC=CC=1)CC1=CC=CC=C1 WWTBZEKOSBFBEM-SPWPXUSOSA-N 0.000 description 1
- STBLNCCBQMHSRC-BATDWUPUSA-N (2s)-n-[(3s,4s)-5-acetyl-7-cyano-4-methyl-1-[(2-methylnaphthalen-1-yl)methyl]-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide Chemical compound O=C1[C@@H](NC(=O)[C@H](C)NC)[C@H](C)N(C(C)=O)C2=CC(C#N)=CC=C2N1CC1=C(C)C=CC2=CC=CC=C12 STBLNCCBQMHSRC-BATDWUPUSA-N 0.000 description 1
- FNHHVPPSBFQMEL-KQHDFZBMSA-N (3S)-5-N-[(1S,5R)-3-hydroxy-6-bicyclo[3.1.0]hexanyl]-7-N,3-dimethyl-3-phenyl-2H-1-benzofuran-5,7-dicarboxamide Chemical compound CNC(=O)c1cc(cc2c1OC[C@@]2(C)c1ccccc1)C(=O)NC1[C@H]2CC(O)C[C@@H]12 FNHHVPPSBFQMEL-KQHDFZBMSA-N 0.000 description 1
- IWZSHWBGHQBIML-ZGGLMWTQSA-N (3S,8S,10R,13S,14S,17S)-17-isoquinolin-7-yl-N,N,10,13-tetramethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-amine Chemical compound CN(C)[C@H]1CC[C@]2(C)C3CC[C@@]4(C)[C@@H](CC[C@@H]4c4ccc5ccncc5c4)[C@@H]3CC=C2C1 IWZSHWBGHQBIML-ZGGLMWTQSA-N 0.000 description 1
- UDQTXCHQKHIQMH-KYGLGHNPSA-N (3ar,5s,6s,7r,7ar)-5-(difluoromethyl)-2-(ethylamino)-5,6,7,7a-tetrahydro-3ah-pyrano[3,2-d][1,3]thiazole-6,7-diol Chemical compound S1C(NCC)=N[C@H]2[C@@H]1O[C@H](C(F)F)[C@@H](O)[C@@H]2O UDQTXCHQKHIQMH-KYGLGHNPSA-N 0.000 description 1
- OOKAZRDERJMRCJ-KOUAFAAESA-N (3r)-7-[(1s,2s,4ar,6s,8s)-2,6-dimethyl-8-[(2s)-2-methylbutanoyl]oxy-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl]-3-hydroxy-5-oxoheptanoic acid Chemical compound C1=C[C@H](C)[C@H](CCC(=O)C[C@@H](O)CC(O)=O)C2[C@@H](OC(=O)[C@@H](C)CC)C[C@@H](C)C[C@@H]21 OOKAZRDERJMRCJ-KOUAFAAESA-N 0.000 description 1
- MPDDTAJMJCESGV-CTUHWIOQSA-M (3r,5r)-7-[2-(4-fluorophenyl)-5-[methyl-[(1r)-1-phenylethyl]carbamoyl]-4-propan-2-ylpyrazol-3-yl]-3,5-dihydroxyheptanoate Chemical compound C1([C@@H](C)N(C)C(=O)C2=NN(C(CC[C@@H](O)C[C@@H](O)CC([O-])=O)=C2C(C)C)C=2C=CC(F)=CC=2)=CC=CC=C1 MPDDTAJMJCESGV-CTUHWIOQSA-M 0.000 description 1
- YQOLEILXOBUDMU-KRWDZBQOSA-N (4R)-5-[(6-bromo-3-methyl-2-pyrrolidin-1-ylquinoline-4-carbonyl)amino]-4-(2-chlorophenyl)pentanoic acid Chemical compound CC1=C(C2=C(C=CC(=C2)Br)N=C1N3CCCC3)C(=O)NC[C@H](CCC(=O)O)C4=CC=CC=C4Cl YQOLEILXOBUDMU-KRWDZBQOSA-N 0.000 description 1
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- DEVSOMFAQLZNKR-RJRFIUFISA-N (z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-n'-pyrazin-2-ylprop-2-enehydrazide Chemical compound FC(F)(F)C1=CC(C(F)(F)F)=CC(C2=NN(\C=C/C(=O)NNC=3N=CC=NC=3)C=N2)=C1 DEVSOMFAQLZNKR-RJRFIUFISA-N 0.000 description 1
- 101150084750 1 gene Proteins 0.000 description 1
- KKHFRAFPESRGGD-UHFFFAOYSA-N 1,3-dimethyl-7-[3-(n-methylanilino)propyl]purine-2,6-dione Chemical compound C1=NC=2N(C)C(=O)N(C)C(=O)C=2N1CCCN(C)C1=CC=CC=C1 KKHFRAFPESRGGD-UHFFFAOYSA-N 0.000 description 1
- KQZLRWGGWXJPOS-NLFPWZOASA-N 1-[(1R)-1-(2,4-dichlorophenyl)ethyl]-6-[(4S,5R)-4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-5-methylcyclohexen-1-yl]pyrazolo[3,4-b]pyrazine-3-carbonitrile Chemical compound ClC1=C(C=CC(=C1)Cl)[C@@H](C)N1N=C(C=2C1=NC(=CN=2)C1=CC[C@@H]([C@@H](C1)C)N1[C@@H](CCC1)CO)C#N KQZLRWGGWXJPOS-NLFPWZOASA-N 0.000 description 1
- WZZBNLYBHUDSHF-DHLKQENFSA-N 1-[(3s,4s)-4-[8-(2-chloro-4-pyrimidin-2-yloxyphenyl)-7-fluoro-2-methylimidazo[4,5-c]quinolin-1-yl]-3-fluoropiperidin-1-yl]-2-hydroxyethanone Chemical compound CC1=NC2=CN=C3C=C(F)C(C=4C(=CC(OC=5N=CC=CN=5)=CC=4)Cl)=CC3=C2N1[C@H]1CCN(C(=O)CO)C[C@@H]1F WZZBNLYBHUDSHF-DHLKQENFSA-N 0.000 description 1
- UNILWMWFPHPYOR-KXEYIPSPSA-M 1-[6-[2-[3-[3-[3-[2-[2-[3-[[2-[2-[[(2r)-1-[[2-[[(2r)-1-[3-[2-[2-[3-[[2-(2-amino-2-oxoethoxy)acetyl]amino]propoxy]ethoxy]ethoxy]propylamino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-[(2r)-2,3-di(hexadecanoyloxy)propyl]sulfanyl-1-oxopropan-2-yl Chemical compound O=C1C(SCCC(=O)NCCCOCCOCCOCCCNC(=O)COCC(=O)N[C@@H](CSC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)NCC(=O)N[C@H](CO)C(=O)NCCCOCCOCCOCCCNC(=O)COCC(N)=O)CC(=O)N1CCNC(=O)CCCCCN\1C2=CC=C(S([O-])(=O)=O)C=C2CC/1=C/C=C/C=C/C1=[N+](CC)C2=CC=C(S([O-])(=O)=O)C=C2C1 UNILWMWFPHPYOR-KXEYIPSPSA-M 0.000 description 1
- WGFNXGPBPIJYLI-UHFFFAOYSA-N 2,6-difluoro-3-[(3-fluorophenyl)sulfonylamino]-n-(3-methoxy-1h-pyrazolo[3,4-b]pyridin-5-yl)benzamide Chemical compound C1=C2C(OC)=NNC2=NC=C1NC(=O)C(C=1F)=C(F)C=CC=1NS(=O)(=O)C1=CC=CC(F)=C1 WGFNXGPBPIJYLI-UHFFFAOYSA-N 0.000 description 1
- OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-dimethylpyridine Chemical class CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 description 1
- FQMZXMVHHKXGTM-UHFFFAOYSA-N 2-(1-adamantyl)-n-[2-[2-(2-hydroxyethylamino)ethylamino]quinolin-5-yl]acetamide Chemical compound C1C(C2)CC(C3)CC2CC13CC(=O)NC1=CC=CC2=NC(NCCNCCO)=CC=C21 FQMZXMVHHKXGTM-UHFFFAOYSA-N 0.000 description 1
- VCUXVXLUOHDHKK-UHFFFAOYSA-N 2-(2-aminopyrimidin-4-yl)-4-(2-chloro-4-methoxyphenyl)-1,3-thiazole-5-carboxamide Chemical compound ClC1=CC(OC)=CC=C1C1=C(C(N)=O)SC(C=2N=C(N)N=CC=2)=N1 VCUXVXLUOHDHKK-UHFFFAOYSA-N 0.000 description 1
- QEBYEVQKHRUYPE-UHFFFAOYSA-N 2-(2-chlorophenyl)-5-[(1-methylpyrazol-3-yl)methyl]-4-[[methyl(pyridin-3-ylmethyl)amino]methyl]-1h-pyrazolo[4,3-c]pyridine-3,6-dione Chemical compound C1=CN(C)N=C1CN1C(=O)C=C2NN(C=3C(=CC=CC=3)Cl)C(=O)C2=C1CN(C)CC1=CC=CN=C1 QEBYEVQKHRUYPE-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- PYRKKGOKRMZEIT-UHFFFAOYSA-N 2-[6-(2-cyclopropylethoxy)-9-(2-hydroxy-2-methylpropyl)-1h-phenanthro[9,10-d]imidazol-2-yl]-5-fluorobenzene-1,3-dicarbonitrile Chemical compound C1=C2C3=CC(CC(C)(O)C)=CC=C3C=3NC(C=4C(=CC(F)=CC=4C#N)C#N)=NC=3C2=CC=C1OCCC1CC1 PYRKKGOKRMZEIT-UHFFFAOYSA-N 0.000 description 1
- VVCMGAUPZIKYTH-VGHSCWAPSA-N 2-acetyloxybenzoic acid;[(2s,3r)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl] propanoate;1,3,7-trimethylpurine-2,6-dione Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O.CN1C(=O)N(C)C(=O)C2=C1N=CN2C.C([C@](OC(=O)CC)([C@H](C)CN(C)C)C=1C=CC=CC=1)C1=CC=CC=C1 VVCMGAUPZIKYTH-VGHSCWAPSA-N 0.000 description 1
- YSUIQYOGTINQIN-UZFYAQMZSA-N 2-amino-9-[(1S,6R,8R,9S,10R,15R,17R,18R)-8-(6-aminopurin-9-yl)-9,18-difluoro-3,12-dihydroxy-3,12-bis(sulfanylidene)-2,4,7,11,13,16-hexaoxa-3lambda5,12lambda5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one Chemical compound NC1=NC2=C(N=CN2[C@@H]2O[C@@H]3COP(S)(=O)O[C@@H]4[C@@H](COP(S)(=O)O[C@@H]2[C@@H]3F)O[C@H]([C@H]4F)N2C=NC3=C2N=CN=C3N)C(=O)N1 YSUIQYOGTINQIN-UZFYAQMZSA-N 0.000 description 1
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 1
- LFOIDLOIBZFWDO-UHFFFAOYSA-N 2-methoxy-6-[6-methoxy-4-[(3-phenylmethoxyphenyl)methoxy]-1-benzofuran-2-yl]imidazo[2,1-b][1,3,4]thiadiazole Chemical compound N1=C2SC(OC)=NN2C=C1C(OC1=CC(OC)=C2)=CC1=C2OCC(C=1)=CC=CC=1OCC1=CC=CC=C1 LFOIDLOIBZFWDO-UHFFFAOYSA-N 0.000 description 1
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- DFRAKBCRUYUFNT-UHFFFAOYSA-N 3,8-dicyclohexyl-2,4,7,9-tetrahydro-[1,3]oxazino[5,6-h][1,3]benzoxazine Chemical compound C1CCCCC1N1CC(C=CC2=C3OCN(C2)C2CCCCC2)=C3OC1 DFRAKBCRUYUFNT-UHFFFAOYSA-N 0.000 description 1
- QBWKPGNFQQJGFY-QLFBSQMISA-N 3-[(1r)-1-[(2r,6s)-2,6-dimethylmorpholin-4-yl]ethyl]-n-[6-methyl-3-(1h-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine Chemical compound N1([C@H](C)C2=NSC(NC=3C4=NC=C(N4C=C(C)N=3)C3=CNN=C3)=C2)C[C@H](C)O[C@H](C)C1 QBWKPGNFQQJGFY-QLFBSQMISA-N 0.000 description 1
- WFOVEDJTASPCIR-UHFFFAOYSA-N 3-[(4-methyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)methylamino]-n-[[2-(trifluoromethyl)phenyl]methyl]benzamide Chemical compound N=1N=C(C=2C=CN=CC=2)N(C)C=1CNC(C=1)=CC=CC=1C(=O)NCC1=CC=CC=C1C(F)(F)F WFOVEDJTASPCIR-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- 125000003974 3-carbamimidamidopropyl group Chemical group C(N)(=N)NCCC* 0.000 description 1
- WYFCZWSWFGJODV-MIANJLSGSA-N 4-[[(1s)-2-[(e)-3-[3-chloro-2-fluoro-6-(tetrazol-1-yl)phenyl]prop-2-enoyl]-5-(4-methyl-2-oxopiperazin-1-yl)-3,4-dihydro-1h-isoquinoline-1-carbonyl]amino]benzoic acid Chemical compound O=C1CN(C)CCN1C1=CC=CC2=C1CCN(C(=O)\C=C\C=1C(=CC=C(Cl)C=1F)N1N=NN=C1)[C@@H]2C(=O)NC1=CC=C(C(O)=O)C=C1 WYFCZWSWFGJODV-MIANJLSGSA-N 0.000 description 1
- MPMKMQHJHDHPBE-RUZDIDTESA-N 4-[[(2r)-1-(1-benzothiophene-3-carbonyl)-2-methylazetidine-2-carbonyl]-[(3-chlorophenyl)methyl]amino]butanoic acid Chemical compound O=C([C@@]1(N(CC1)C(=O)C=1C2=CC=CC=C2SC=1)C)N(CCCC(O)=O)CC1=CC=CC(Cl)=C1 MPMKMQHJHDHPBE-RUZDIDTESA-N 0.000 description 1
- 125000003143 4-hydroxybenzyl group Chemical group [H]C([*])([H])C1=C([H])C([H])=C(O[H])C([H])=C1[H] 0.000 description 1
- VKLKXFOZNHEBSW-UHFFFAOYSA-N 5-[[3-[(4-morpholin-4-ylbenzoyl)amino]phenyl]methoxy]pyridine-3-carboxamide Chemical compound O1CCN(CC1)C1=CC=C(C(=O)NC=2C=C(COC=3C=NC=C(C(=O)N)C=3)C=CC=2)C=C1 VKLKXFOZNHEBSW-UHFFFAOYSA-N 0.000 description 1
- XFJBGINZIMNZBW-CRAIPNDOSA-N 5-chloro-2-[4-[(1r,2s)-2-[2-(5-methylsulfonylpyridin-2-yl)oxyethyl]cyclopropyl]piperidin-1-yl]pyrimidine Chemical compound N1=CC(S(=O)(=O)C)=CC=C1OCC[C@H]1[C@@H](C2CCN(CC2)C=2N=CC(Cl)=CN=2)C1 XFJBGINZIMNZBW-CRAIPNDOSA-N 0.000 description 1
- GDUANFXPOZTYKS-UHFFFAOYSA-N 6-bromo-8-[(2,6-difluoro-4-methoxybenzoyl)amino]-4-oxochromene-2-carboxylic acid Chemical compound FC1=CC(OC)=CC(F)=C1C(=O)NC1=CC(Br)=CC2=C1OC(C(O)=O)=CC2=O GDUANFXPOZTYKS-UHFFFAOYSA-N 0.000 description 1
- XASOHFCUIQARJT-UHFFFAOYSA-N 8-methoxy-6-[7-(2-morpholin-4-ylethoxy)imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one Chemical compound C(N1C(=O)C2=C(OC)C=C(C=3N4C(=NC=3)C=C(C=C4)OCCN3CCOCC3)C=C2CC1)C(F)(F)F XASOHFCUIQARJT-UHFFFAOYSA-N 0.000 description 1
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 1
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 241000432824 Asparagus densiflorus Species 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241001480061 Blumeria graminis Species 0.000 description 1
- 241000123650 Botrytis cinerea Species 0.000 description 1
- JQUCWIWWWKZNCS-LESHARBVSA-N C(C1=CC=CC=C1)(=O)NC=1SC[C@H]2[C@@](N1)(CO[C@H](C2)C)C=2SC=C(N2)NC(=O)C2=NC=C(C=C2)OC(F)F Chemical compound C(C1=CC=CC=C1)(=O)NC=1SC[C@H]2[C@@](N1)(CO[C@H](C2)C)C=2SC=C(N2)NC(=O)C2=NC=C(C=C2)OC(F)F JQUCWIWWWKZNCS-LESHARBVSA-N 0.000 description 1
- BQXUPNKLZNSUMC-YUQWMIPFSA-N CCN(CCCCCOCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)N[C@@H](C)c1ccc(cc1)-c1scnc1C)C(C)(C)C)CCOc1ccc(cc1)C(=O)c1c(sc2cc(O)ccc12)-c1ccc(O)cc1 Chemical compound CCN(CCCCCOCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)N[C@@H](C)c1ccc(cc1)-c1scnc1C)C(C)(C)C)CCOc1ccc(cc1)C(=O)c1c(sc2cc(O)ccc12)-c1ccc(O)cc1 BQXUPNKLZNSUMC-YUQWMIPFSA-N 0.000 description 1
- PKMUHQIDVVOXHQ-HXUWFJFHSA-N C[C@H](C1=CC(C2=CC=C(CNC3CCCC3)S2)=CC=C1)NC(C1=C(C)C=CC(NC2CNC2)=C1)=O Chemical compound C[C@H](C1=CC(C2=CC=C(CNC3CCCC3)S2)=CC=C1)NC(C1=C(C)C=CC(NC2CNC2)=C1)=O PKMUHQIDVVOXHQ-HXUWFJFHSA-N 0.000 description 1
- 101100256918 Caenorhabditis elegans sid-2 gene Proteins 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000001250 Cardamine diphylla Nutrition 0.000 description 1
- 244000250392 Cardamine diphylla Species 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 229940126657 Compound 17 Drugs 0.000 description 1
- 229940126639 Compound 33 Drugs 0.000 description 1
- 101000783577 Dendroaspis angusticeps Thrombostatin Proteins 0.000 description 1
- 101000783578 Dendroaspis jamesoni kaimosae Dendroaspin Proteins 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical compound C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 description 1
- 101150031726 ERS1 gene Proteins 0.000 description 1
- 241000221785 Erysiphales Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 101150115493 FAD3 gene Proteins 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 101000732336 Homo sapiens Transcription factor AP-2 gamma Proteins 0.000 description 1
- 101000802094 Homo sapiens mRNA decay activator protein ZFP36L1 Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 101100464974 Medicago truncatula PR-1 gene Proteins 0.000 description 1
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 1
- AVYVHIKSFXVDBG-UHFFFAOYSA-N N-benzyl-N-hydroxy-2,2-dimethylbutanamide Chemical compound C(C1=CC=CC=C1)N(C(C(CC)(C)C)=O)O AVYVHIKSFXVDBG-UHFFFAOYSA-N 0.000 description 1
- OPFJDXRVMFKJJO-ZHHKINOHSA-N N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-G-dR-G-dD-dD-dD-NH2 Chemical compound S1C(C=2NN=C(C=2)C(=O)NCC(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(N)=O)=C(C)N=C1NC(=O)C1=CC=CC=C1 OPFJDXRVMFKJJO-ZHHKINOHSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- QOVYHDHLFPKQQG-NDEPHWFRSA-N N[C@@H](CCC(=O)N1CCC(CC1)NC1=C2C=CC=CC2=NC(NCC2=CN(CCCNCCCNC3CCCCC3)N=N2)=N1)C(O)=O Chemical compound N[C@@H](CCC(=O)N1CCC(CC1)NC1=C2C=CC=CC2=NC(NCC2=CN(CCCNCCCNC3CCCCC3)N=N2)=N1)C(O)=O QOVYHDHLFPKQQG-NDEPHWFRSA-N 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 108700001094 Plant Genes Proteins 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- 101100204733 Schizosaccharomyces pombe (strain 972 / ATCC 24843) gus1 gene Proteins 0.000 description 1
- PNUZDKCDAWUEGK-CYZMBNFOSA-N Sitafloxacin Chemical compound C([C@H]1N)N(C=2C(=C3C(C(C(C(O)=O)=CN3[C@H]3[C@H](C3)F)=O)=CC=2F)Cl)CC11CC1 PNUZDKCDAWUEGK-CYZMBNFOSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- 101000611441 Solanum lycopersicum Pathogenesis-related leaf protein 6 Proteins 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 208000002564 X-linked cardiac valvular dysplasia Diseases 0.000 description 1
- LJOOWESTVASNOG-UFJKPHDISA-N [(1s,3r,4ar,7s,8s,8as)-3-hydroxy-8-[2-[(4r)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl] (2s)-2-methylbutanoate Chemical compound C([C@H]1[C@@H](C)C=C[C@H]2C[C@@H](O)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)CC1C[C@@H](O)CC(=O)O1 LJOOWESTVASNOG-UFJKPHDISA-N 0.000 description 1
- SPXSEZMVRJLHQG-XMMPIXPASA-N [(2R)-1-[[4-[(3-phenylmethoxyphenoxy)methyl]phenyl]methyl]pyrrolidin-2-yl]methanol Chemical compound C(C1=CC=CC=C1)OC=1C=C(OCC2=CC=C(CN3[C@H](CCC3)CO)C=C2)C=CC=1 SPXSEZMVRJLHQG-XMMPIXPASA-N 0.000 description 1
- LNUFLCYMSVYYNW-ZPJMAFJPSA-N [(2r,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[[(3s,5s,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]-4,5-disulfo Chemical compound O([C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1C[C@@H]2CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CCCC(C)C)[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]1OS(O)(=O)=O LNUFLCYMSVYYNW-ZPJMAFJPSA-N 0.000 description 1
- PSLUFJFHTBIXMW-WYEYVKMPSA-N [(3r,4ar,5s,6s,6as,10s,10ar,10bs)-3-ethenyl-10,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-6-(2-pyridin-2-ylethylcarbamoyloxy)-5,6,6a,8,9,10-hexahydro-2h-benzo[f]chromen-5-yl] acetate Chemical compound O([C@@H]1[C@@H]([C@]2(O[C@](C)(CC(=O)[C@]2(O)[C@@]2(C)[C@@H](O)CCC(C)(C)[C@@H]21)C=C)C)OC(=O)C)C(=O)NCCC1=CC=CC=N1 PSLUFJFHTBIXMW-WYEYVKMPSA-N 0.000 description 1
- CIGIRZIOSVQVKQ-UHFFFAOYSA-N [O].CCCCCCCCCCCCCCCCCC Chemical compound [O].CCCCCCCCCCCCCCCCCC CIGIRZIOSVQVKQ-UHFFFAOYSA-N 0.000 description 1
- SMNRFWMNPDABKZ-WVALLCKVSA-N [[(2R,3S,4R,5S)-5-(2,6-dioxo-3H-pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [[[(2R,3S,4S,5R,6R)-4-fluoro-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl] hydrogen phosphate Chemical compound OC[C@H]1O[C@H](OP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)C2C=CC(=O)NC2=O)[C@H](O)[C@@H](F)[C@@H]1O SMNRFWMNPDABKZ-WVALLCKVSA-N 0.000 description 1
- 229940008309 acetone / ethanol Drugs 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000010441 alabaster Substances 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- BHELZAPQIKSEDF-UHFFFAOYSA-N allyl bromide Chemical compound BrCC=C BHELZAPQIKSEDF-UHFFFAOYSA-N 0.000 description 1
- DCAYPVUWAIABOU-UHFFFAOYSA-N alpha-n-hexadecene Natural products CCCCCCCCCCCCCCCC DCAYPVUWAIABOU-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 159000000013 aluminium salts Chemical class 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 229910000329 aluminium sulfate Inorganic materials 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 230000002744 anti-aggregatory effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 229940127218 antiplatelet drug Drugs 0.000 description 1
- 229910052586 apatite Inorganic materials 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 150000003851 azoles Chemical class 0.000 description 1
- 159000000009 barium salts Chemical class 0.000 description 1
- OKMQKGODLHNLGC-UHFFFAOYSA-N benzene;methanethiol Chemical compound SC.C1=CC=CC=C1 OKMQKGODLHNLGC-UHFFFAOYSA-N 0.000 description 1
- YAVVGPBYBUYPSR-UHFFFAOYSA-N benzene;oxygen Chemical compound [O].C1=CC=CC=C1 YAVVGPBYBUYPSR-UHFFFAOYSA-N 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 1
- 229940073608 benzyl chloride Drugs 0.000 description 1
- KGNDCEVUMONOKF-UGPLYTSKSA-N benzyl n-[(2r)-1-[(2s,4r)-2-[[(2s)-6-amino-1-(1,3-benzoxazol-2-yl)-1,1-dihydroxyhexan-2-yl]carbamoyl]-4-[(4-methylphenyl)methoxy]pyrrolidin-1-yl]-1-oxo-4-phenylbutan-2-yl]carbamate Chemical compound C1=CC(C)=CC=C1CO[C@H]1CN(C(=O)[C@@H](CCC=2C=CC=CC=2)NC(=O)OCC=2C=CC=CC=2)[C@H](C(=O)N[C@@H](CCCCN)C(O)(O)C=2OC3=CC=CC=C3N=2)C1 KGNDCEVUMONOKF-UGPLYTSKSA-N 0.000 description 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 1
- 108010089934 carbohydrase Proteins 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000002595 cold damage Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 229940125773 compound 10 Drugs 0.000 description 1
- 229940126543 compound 14 Drugs 0.000 description 1
- 229940125758 compound 15 Drugs 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 229940126086 compound 21 Drugs 0.000 description 1
- 229940126208 compound 22 Drugs 0.000 description 1
- 229940125833 compound 23 Drugs 0.000 description 1
- 229940125846 compound 25 Drugs 0.000 description 1
- 229940127204 compound 29 Drugs 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
- 229940125877 compound 31 Drugs 0.000 description 1
- 229940125878 compound 36 Drugs 0.000 description 1
- 229940127573 compound 38 Drugs 0.000 description 1
- 229940126540 compound 41 Drugs 0.000 description 1
- 229940125936 compound 42 Drugs 0.000 description 1
- 229940125844 compound 46 Drugs 0.000 description 1
- 229940127271 compound 49 Drugs 0.000 description 1
- 229940126545 compound 53 Drugs 0.000 description 1
- 229940126179 compound 72 Drugs 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 239000013530 defoamer Substances 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 229940043237 diethanolamine Drugs 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N dimethylmethane Natural products CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- BJXYHBKEQFQVES-NWDGAFQWSA-N enpatoran Chemical compound N[C@H]1CN(C[C@H](C1)C(F)(F)F)C1=C2C=CC=NC2=C(C=C1)C#N BJXYHBKEQFQVES-NWDGAFQWSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- GWNFQAKCJYEJEW-UHFFFAOYSA-N ethyl 3-[8-[[4-methyl-5-[(3-methyl-4-oxophthalazin-1-yl)methyl]-1,2,4-triazol-3-yl]sulfanyl]octanoylamino]benzoate Chemical compound CCOC(=O)C1=CC(NC(=O)CCCCCCCSC2=NN=C(CC3=NN(C)C(=O)C4=CC=CC=C34)N2C)=CC=C1 GWNFQAKCJYEJEW-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- DWYMPOCYEZONEA-UHFFFAOYSA-L fluoridophosphate Chemical compound [O-]P([O-])(F)=O DWYMPOCYEZONEA-UHFFFAOYSA-L 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 229930182480 glucuronide Natural products 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 150000002306 glutamic acid derivatives Chemical class 0.000 description 1
- 239000010440 gypsum Substances 0.000 description 1
- 229910052602 gypsum Inorganic materials 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000003104 hexanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000001744 histochemical effect Effects 0.000 description 1
- 125000004464 hydroxyphenyl group Chemical group 0.000 description 1
- 125000002140 imidazol-4-yl group Chemical group [H]N1C([H])=NC([*])=C1[H] 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 230000002015 leaf growth Effects 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- RENRQMCACQEWFC-UGKGYDQZSA-N lnp023 Chemical compound C1([C@H]2N(CC=3C=4C=CNC=4C(C)=CC=3OC)CC[C@@H](C2)OCC)=CC=C(C(O)=O)C=C1 RENRQMCACQEWFC-UGKGYDQZSA-N 0.000 description 1
- 102100034702 mRNA decay activator protein ZFP36L1 Human genes 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 125000004092 methylthiomethyl group Chemical group [H]C([H])([H])SC([H])([H])* 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 239000002068 microbial inoculum Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- YCJZWBZJSYLMPB-UHFFFAOYSA-N n-(2-chloropyrimidin-4-yl)-2,5-dimethyl-1-phenylimidazole-4-carboxamide Chemical compound CC=1N(C=2C=CC=CC=2)C(C)=NC=1C(=O)NC1=CC=NC(Cl)=N1 YCJZWBZJSYLMPB-UHFFFAOYSA-N 0.000 description 1
- YGBMCLDVRUGXOV-UHFFFAOYSA-N n-[6-[6-chloro-5-[(4-fluorophenyl)sulfonylamino]pyridin-3-yl]-1,3-benzothiazol-2-yl]acetamide Chemical compound C1=C2SC(NC(=O)C)=NC2=CC=C1C(C=1)=CN=C(Cl)C=1NS(=O)(=O)C1=CC=C(F)C=C1 YGBMCLDVRUGXOV-UHFFFAOYSA-N 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- IOMMMLWIABWRKL-WUTDNEBXSA-N nazartinib Chemical compound C1N(C(=O)/C=C/CN(C)C)CCCC[C@H]1N1C2=C(Cl)C=CC=C2N=C1NC(=O)C1=CC=NC(C)=C1 IOMMMLWIABWRKL-WUTDNEBXSA-N 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- PIDFDZJZLOTZTM-KHVQSSSXSA-N ombitasvir Chemical compound COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)NC1=CC=C([C@H]2N([C@@H](CC2)C=2C=CC(NC(=O)[C@H]3N(CCC3)C(=O)[C@@H](NC(=O)OC)C(C)C)=CC=2)C=2C=CC(=CC=2)C(C)(C)C)C=C1 PIDFDZJZLOTZTM-KHVQSSSXSA-N 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 125000005489 p-toluenesulfonic acid group Chemical class 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- BOTNYLSAWDQNEX-UHFFFAOYSA-N phenoxymethylbenzene Chemical compound C=1C=CC=CC=1COC1=CC=CC=C1 BOTNYLSAWDQNEX-UHFFFAOYSA-N 0.000 description 1
- QCCDLTOVEPVEJK-UHFFFAOYSA-N phenylacetone Chemical class CC(=O)CC1=CC=CC=C1 QCCDLTOVEPVEJK-UHFFFAOYSA-N 0.000 description 1
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- LGRFSURHDFAFJT-UHFFFAOYSA-N phthalic anhydride Chemical compound C1=CC=C2C(=O)OC(=O)C2=C1 LGRFSURHDFAFJT-UHFFFAOYSA-N 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000000106 platelet aggregation inhibitor Substances 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- SSOLNOMRVKKSON-UHFFFAOYSA-N proguanil Chemical compound CC(C)\N=C(/N)N=C(N)NC1=CC=C(Cl)C=C1 SSOLNOMRVKKSON-UHFFFAOYSA-N 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000013849 propane Nutrition 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical class CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000008653 root damage Effects 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 230000035040 seed growth Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 125000003696 stearoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 229960005137 succinic acid Drugs 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/44—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio analogue of a carboxylic group, e.g. amino-carboxylic acids
- A01N37/46—N-acyl derivatives
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N33/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds
- A01N33/02—Amines; Quaternary ammonium compounds
- A01N33/08—Amines; Quaternary ammonium compounds containing oxygen or sulfur
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
- A01N43/50—1,3-Diazoles; Hydrogenated 1,3-diazoles
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/18—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group —CO—N<, e.g. carboxylic acid amides or imides; Thio analogues thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N41/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a sulfur atom bound to a hetero atom
- A01N41/12—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a sulfur atom bound to a hetero atom not containing sulfur-to-oxygen bonds, e.g. polysulfides
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
- A01N43/36—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom five-membered rings
- A01N43/38—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom five-membered rings condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
- A01N47/08—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
- A01N47/10—Carbamic acid derivatives, i.e. containing the group —O—CO—N<; Thio analogues thereof
- A01N47/12—Carbamic acid derivatives, i.e. containing the group —O—CO—N<; Thio analogues thereof containing a —O—CO—N< group, or a thio analogue thereof, neither directly attached to a ring nor the nitrogen atom being a member of a heterocyclic ring
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
- A01N47/40—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having a double or triple bond to nitrogen, e.g. cyanates, cyanamides
- A01N47/42—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having a double or triple bond to nitrogen, e.g. cyanates, cyanamides containing —N=CX2 groups, e.g. isothiourea
- A01N47/44—Guanidine; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C07K5/06043—Leu-amino acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C07K5/06052—Val-amino acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
- C07K5/06069—Ser-amino acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06086—Dipeptides with the first amino acid being basic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06086—Dipeptides with the first amino acid being basic
- C07K5/06095—Arg-amino acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06104—Dipeptides with the first amino acid being acidic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06104—Dipeptides with the first amino acid being acidic
- C07K5/06113—Asp- or Asn-amino acid
- C07K5/06121—Asp- or Asn-amino acid the second amino acid being aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- C07K5/06147—Dipeptides with the first amino acid being heterocyclic and His-amino acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- C07K5/06156—Dipeptides with the first amino acid being heterocyclic and Trp-amino acid; Derivatives thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Pest Control & Pesticides (AREA)
- Agronomy & Crop Science (AREA)
- Plant Pathology (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Cultivation Of Plants (AREA)
Abstract
本发明提供的是农业植物‑保护剂,其包括二肽衍生物或其农药学可接受的盐作为活性成分,其具有植物疾病‑预防效应,植物生长‑促进效应,及植物免疫‑活化效应。
Description
【技术领域】
本发明涉及包含二肽衍生物或其农药学可接受的盐作为活性成分的农业植物-保护剂,其具有植物疾病-预防效应,植物生长-促进效应,及植物免疫-活化效应。
【背景技术】
当植物被病原体侵袭或受物理损伤时,为防御目的而产生信号传导分子。已知,该信号传导分子具有作为植物防御活化物,植物加强剂,或植物免疫活化物的效应。作为植物的代表性的信号传导分子,已知道水杨酸和茉莉酸。当由于外部侵入而植物的防御反应发挥作用时,水杨酸(信号传导分子)诱导植物中基因,诸如,PR-1,BGL-2,PR-5,SID-2,EDS-5和PAD-4表达,及茉莉酸诱导植物中基因,诸如,PDF1.2,VSP,HEL,THI-2,FAD3,ERS1和ERF1表达[Dong,X.,Current Opinion in Plant Biology,1998,1,316-323;Glazebrook,J.,Current Opinion in Plant Biology,1999,2,280-286;Bostock,R.M.,Physiology andMolecular Plant Pathology,1999,55,99-109]。特别是,PR-1基因是指示由水杨酸产生的植物抗性-诱导现象的基因,PR-1基因的表达是植物中信号传导过程起动的关键的证据。当植物中PR蛋白表达时,植物显示疾病抗性效应诸如抗细菌性活性。此外,PDF1.2基因是指示由茉莉酸诱导的植物抗性-诱导现象的基因,PDF1.2基因的表达是植物的防御反应起动的信号传导过程进行的关键的证据。
苯并-1,2,3-噻二唑-7-硫代羧酸S-乙基酯(BTH)已商业上用作植物的信号传导分子。BTH是与水杨酸具有类似化学结构的合成化合物。已报道BTH显示抑制导致大麦白粉病的布氏白粉菌(Blumeria graminis)的活性,植物的臭氧抗性,在葡萄植物中呈现对灰葡萄孢(Botrytis cinerea)的抗性,促进白藜芦醇和花青苷生物合成的活性,在草莓中对白粉病的抗性,及也具有酚化合物的蓄积效应。BTH如水杨酸一样具有诱导PR-1基因表达的功能,但不诱导由茉莉酸呈现的PDF1.2基因的表达。
如上所述,当用于植物的自身-防御的信号传导分子诸如水杨酸和茉莉酸诱导基因诸如PR-1或PDF1.2的表达时,植物可抑制病原体的繁殖,也可忍耐物理创伤。换言之,被认为在植物中诱导自身-防御能力。因此,即便未处理常规抗微生物剂或杀菌剂,当该基因在植物中表达时,植物可抵抗病原体。因此认为,使该基因表达的分子作为植物用农业药物具有大的价值。
同时,二肽是具有通过2个氨基酸缩合产生的酰胺键的肽分子。二肽甚至在实施蛋白水解时也以各种类型的结构产生,及甚至还在合成2,5-哌嗪二酮,环状二肽的过程期间产生。阿司帕坦,即,人工甜味剂,属于由2个氨基酸组成的二肽。据至今报道,二肽化合物主要作为人工甜味剂,血小板聚集抑制物等应用[国际专利公开No。WO9616981,US专利No.5,968,581和5,763,408,及欧洲专利公开No.513675]。
本发明人合成了由2个氨基酸制成的二肽衍生物,及发现,当用这些化合物处理植物时,它们表达植物疾病-抵抗基因诸如PR-1,葡聚糖酶,几丁质酶,PR4,过氧化物酶和PR10。此外,我们发现,当用二肽衍生物处理形成损伤之前的植物时,显著地抑制植物中损伤的形成,及除了植物疾病-预防效应之外,也改善植物生长-促进效应和植物免疫-增加效应(详细而言,植物疾病-抵抗能力或植物冷害-预防能力)。由此,本发明人完成了本发明。
换言之,本发明人首次发现,二肽衍生物诱导疾病抗性基因表达,及通过抑制病原体的增殖而显示植物疾病-预防效应,植物生长-促进效应,及植物免疫-增加,而至今这尚未报道于任何现有技术文献。
【发明内容】
【发明要解决的技术课题】
本发明旨在提供二肽衍生物作为农业植物-保护剂的用途。
【解决课题的技术方案】
为了达到该目的,本发明提供农业植物-保护剂,其包含选自以下化学式1所示的二肽衍生物或其农药学可接受的盐的化合物作为活性成分。
[化学式1]
在以上化学式1中,
R1,R2和R5彼此相同或不同,且表示氢原子、线性或分支的C1~C18烷基羰基、线性或分支的C1~C18烷氧基羰基、或
R3,R4,R6和R7彼此相同或不同,且表示氢原子、或被选自下列的基团取代的或未经取代的线性或分支的C1~C18烷基:羟基、巯基、氨基、胍基、N,N-双(苄氧基羰基)胍基、氨基甲酰基、羧酸、线性或分支的C1~C18烷氧基羰基、线性或分支的C1~C18烯基氧基羰基、线性或分支的C1~C18烷硫基、三苯甲硫基、乙酰氨基、苯基、羟苯基、咪唑和吲哚基;
或R3和R4中的任何一个可与R2结合而形成含氮的5-元至7-元环或R6和R7中的任何一个可与R5结合而形成含氮的5-元至7-元环,
R8表示羟基;线性或分支的C1~C18烷氧基;线性或分支的C1~C18烷基氨基;或
Ra表示线性或分支的C1~C18烷基;
n表示0~5的整数,取代基数,Ra;以及
m表示0~6的整数。
此外,本发明提供预防或抑制植物疾病的方法,所述方法包括用包含选自以上化学式1所示的二肽衍生物或其农药学可接受的盐作为活性成分的化合物的农业植物-保护剂处理植物。
此外,本发明提供活化植物免疫的方法,所述方法包括用包含选自以上化学式1所示的二肽衍生物或其农药学可接受的盐作为活性成分的化合物的农业植物-保护剂处理植物。
此外,本发明提供促进植物生长的方法,所述方法包括用包含选自以上化学式1所示的二肽衍生物或其农药学可接受的盐作为活性成分的化合物的农业植物-保护剂处理植物。
【发明效果】
当处理植物时,本发明的农业植物-保护剂由于通过表达植物疾病-抵抗基因诸如PR-1,葡聚糖酶,几丁质酶,PR4,过氧化物酶和PR10,由此诱导植物疾病-抵抗蛋白的产生而阻遏病原体的感染和增殖,从而具有显著地减少植物中损伤形成的效应。此外,本发明的农业植物-保护剂允许植物活化针对病原体的疾病抗性机理或通过起动自身-防御机理来保护自身免于冷害。此外,本发明的农业植物-保护剂允许植物耐受由寒冷或热气候条件导致的环境应激,及也具有促进植物生长的效应。
此外,本发明的农业植物-保护剂由植物的自身-防御机理而具有系统性效应,即该效也在未处理的其他区显现。换言之,即使剂处理植物的一部分,诸如植物的种子,根,茎和叶,其在其他未处理的区,及甚至在收获的果实上也具有效应。
由于农业植物-保护剂对预防由细菌,病毒,或霉菌导致的植物疾病诸如细菌性软化病,猝倒病,疫霉枯萎病,萎缩病,叶斑病或花叶病具有优良效果,其作为能取代常规杀菌剂使用的环境-友好的农业植物-保护剂有用。
本发明的农业植物-保护剂在应用于如下植物的情况中具有优良效果,所述植物如双子叶植物,例如,茄科(solanaceae)诸如马铃薯,辣椒,甜椒,及番茄,葫芦科(cucurbitaceae),诸如黄瓜,烟草,西瓜和东瓜,十字花科植物(十字花科(cruciferae))诸如白菜,莴苣,萝卜,卷心菜,油菜,花生,及芹菜,医药植物,诸如人参和当归,植物,诸如紫苏子,草莓,葱,大蒜,姜和洋葱,禾本科(graminae),诸如,稻,大麦,玉米和高粱,及果树,诸如苹果树,梨树,桃树和柿树。
【附图说明】
图1是显示用化合物80和化合物89处理辣椒植物的情况中表达的防御基因的表达程度的图。在图1中,(a)及(b)是在自用化合物80处理辣椒幼苗之后1周后,在接种导致细菌性软化病的胡萝卜软腐果胶杆菌(Pectobacterium carotovora)之后12和24小时测量基因表达的结果。在图1中,(c)及(d)是显示在自用化合物80处理及接种疫霉(辣椒疫霉(Phytophthora capsici))起12和24小时之后产生的防御基因表达程度的结果(1.对照组;2.用病原体处理;3.用0.1mM BTH处理;4.用0.1mM BTH和病原体处理;5.用0.1ppm的化合物80处理;6.用0.1ppm的化合物80和病原体处理;7.用1.0ppm的化合物80处理;8.用1.0ppm的化合物80和病原体处理;9.用10.0ppm的化合物80处理;10.用10.0ppm的化合物80和病原体处理)。在图1中,(e)是显示用化合物89处理,并在3天后接种辣椒疫霉(Phytophthoracapsici),过12小时之后产生的防御基因表达程度的结果(1.对照组,0小时;2.对照组,12小时;3.0.1mM的BTH,0小时;4.0.1mM的BTH,12小时;5.0.1ppm的化合物89,0小时;6.0.1ppm的化合物89,12小时;7.1.0ppm的化合物89,0小时;8.1.0ppm的化合物89,12小时)。
图2是显示在用化合物74处理烟草植物的情况中产生的GUS的表达程度的照片(X-gluc组织化学染色)。
图3是显示在用化合物处理烟草植物的情况中产生的抑制烟草细菌性软化病(胡萝卜软腐果胶杆菌(Pectobacterium carotovora))的效应的照片。在图3中,(a)是显示在用化合物5(D5)、化合物6(D6)和化合物7(D7)处理的情况中抑制细菌性软化病的效应的照片。在图3中,(b)是显示在用化合物24(D24),化合物27(D27),化合物37(D37),化合物39(D39),及化合物40(D40)处理的情况中的阻遏效应的照片。在图3中,(c)是显示在用化合物51(D51),化合物52(D52),化合物57(D57),化合物59(D59),及化合物60(D60)处理的情况中的阻遏效应的照片。在图3中,(d)是显示在用化合物67(D67),化合物68(D68),化合物75(D75),化合物12(D12),及化合物16(D16)处理的情况中的阻遏效应的照片。
图4是显示在用化合物61(D61)和化合物74(D74)处理黄瓜叶的情况中抑制炭疽病的效应的照片。
图5是显示在将化合物89(D89)以0.1,1.0和10.0ppm的浓度喷到辣椒叶后抑制(a)细菌性软化病(胡萝卜软腐果胶杆菌(Pectobacterium carotovora))及(b)疫霉(辣椒疫霉(Phytophthora capsici))的效应的照片。
图6是显示在用化合物4(D4),6(D6),90(D90),91(D91),92(D92),93(D93),94(D94)和95(D95)分别浸透-处理辣椒叶后抑制在叶上细菌性软化病(胡萝卜软腐果胶杆菌(Pectobacterium carotovora))暴发的现象的照片。
图7是显示在将化合物6(D6),91(D91),93(D93),95(D95)和107(D107)分别喷到辣椒叶上后抑制叶上产生的细菌性软化病(胡萝卜软腐果胶杆菌(Pectobacteriumcarotovora))的暴发的效应的照片。
图8是显示在用化合物4(D4),94(D94),95(D95),107(D107)和109(D109)分别浸透-处理辣椒叶后抑制叶上产生的疫霉(辣椒疫霉(Phytophthora capsici))的暴发的现象的照片。
图9是显示在将化合物4(D4),6(D6),107(D107),108(D108)和109(D109)分别喷到辣椒叶后抑制叶上产生的疫霉(辣椒疫霉(Phytophthora capsici))暴发的现象的照片。
图10是显示在自将化合物85喷射于辣椒叶,然后用疫霉(辣椒疫霉(Phytophthoracapsici))游动孢子的悬浮液浸透-感染根起7天之后观察的叶和根上损伤形成程度的照片((a)对照组;(b)用0.1mM的BTH处理;(c)用10ppm的化合物85处理)。
图11是显示在用化合物95(D95),103(D103)和109(D109)浸透-处理生长6周的辣椒植物;在1周之后,将辣椒植物放置在2℃的生长室1天;然后,使辣椒植物于室温生长3天之后观察的植物的冷害程度的照片。
图12是显示在将化合物4(D4),6(D6),90(D90),91(D91),92(D92),93(D93),94(D94)和95(D95)喷到生长6周的辣椒植物的叶;在1周之后,将辣椒植物放置在2℃的生长室1天;然后,使辣椒植物于室温生长3天之后观察的植物冷害程度的照片。
【实施方式】
本发明涉及农业植物-保护剂,其包含上述化学式1所示的二肽衍生物或其农药学可接受的盐作为活性成分。
对于在农业植物-保护剂中作为活性成分包含的上述化学式1所示的二肽衍生物而言,在具有一个或更多手性碳的情况中,本发明的农业植物-保护剂可包含外消旋混合物或异构化合物类型的上述化学式1所示的化合物作为活性成分。
在本发明中,农药学可接受的盐的例可包括金属盐,与有机碱的盐,与无机酸的盐,与有机酸的盐,与碱性或酸性氨基酸的盐等。适合的金属盐的例可包括碱金属盐,诸如,钠盐和钾盐;碱土金属盐,诸如,钙盐,镁盐,及钡盐;铝盐等。与有机碱的盐的例可包括与三甲基胺,三乙基胺,吡啶,甲基吡啶,2,6-二甲基吡啶,乙醇胺,二乙醇胺,三乙醇胺,环己基胺,二环己基胺,N,N-二苄基亚乙基胺等的盐。与无机酸的盐的例可包括与盐酸,氢溴酸,硝酸,硫酸,磷酸等的盐。与有机酸的盐的例可包括与甲酸,乙酸,三氟乙酸,酞酸,富马酸,草酸,酒石酸,马来酸,柠檬酸,琥珀酸,甲基磺酸,苯磺酸,p-甲苯磺酸等的盐。与碱性氨基酸的盐的例可包括与精氨酸,赖氨酸,鸟氨酸等的盐。与酸性氨基酸的盐的例可包括与天冬氨酸,谷氨酸等的盐。
用于限定根据本发明的上述化学式1所示的二肽衍生物的取代基会更详细描述如下。术语“烷基”在本发明中是指具有1~18个碳原子,优选1~6个碳原子,及更优选1~4个碳原子的线性或分支的烷基。具体而言,其可包括甲基、乙基、n-丙基、异丙基、n-丁基、1-甲基丙基、2-甲基丙基、t-丁基、n-戊基、t-戊基、n-己基、异己基、庚基、辛基、十六烷基、十八烷基等。术语“烷氧基”在本发明中是指O-烷基,及此时烷基如同上述。
此外,对于上述化学式1所示的二肽衍生物,优选,R1,R2和R5彼此相同或不同,且表示氢原子、乙酰基、己酰基、十六烷酰基、十八烷酰基、苯甲酰基、4-己基苯甲酰基、2-苯乙酰基、3-苯基丙酮基、甲氧羰基、乙氧基羰基、t-丁氧羰基、十六氧基羰基、十八氧基羰基、苯氧基羰基、及4-己基苄基氧基羰基;R3,R4,R6和R7彼此相同或不同,且表示氢原子、甲基、乙基、n-丙基、异丙基、1-甲基丙基、2-甲基丙基、羟甲基、1-羟乙基、2-羟乙基、咪唑-4-基-甲基、2-甲硫基乙基、苄基、4-羟基苄基、苯乙基、巯基甲基、甲硫基甲基、甲硫基乙基、三苯甲硫基甲基、三苯甲硫基乙基、甲氧基羰基甲基、乙氧基羰基甲基、丙氧基羰基甲基、叔-丁氧基羰基甲基、戊氧基羰基甲基、己氧基羰基甲基、烯丙氧基羰基甲基、2-烯丙氧基羰基乙基、苄氧基羰基甲基、苄氧基羰基乙基、苯乙氧基羰基甲基、2-苯乙氧基羰基乙基、3-苯基丙氧基羰基甲基、2-(3-苯基丙氧基羰基)乙基、1-甲氧基羰基乙基、2-甲氧基羰基乙基、2-乙氧基羰基乙基、2-丙氧基羰基乙基、2-丁氧基羰基乙基、2-戊氧基羰基乙基、2-己氧基羰基乙基、2-氨基乙基、氨甲酰甲基、2-氨甲酰乙基、乙酰氨基甲基、乙酰氨基乙基、羧甲基、羧乙基、咪唑-4-基甲基、咪唑-4-基乙基、3-胍基丙基、N,N-双(苄氧基羰基)胍基丙基、吲哚-3-基甲基、或吲哚-3-基乙基;或R3和R4中的任何一个可经-(CH2)3-与R2结合而形成含氮的5-元环或R6和R7中的任何一个可经-(CH2)3-与R5结合而形成含氮的5-元环;及R8表示如下化合物,所述化合物表示氢原子,甲氧基、乙氧基、丙氧基、t-丁氧基、己氧基、十六烷氧基、十八烷氧基、苄氧基、苯乙氧基、3-苯基丙氧基、甲氨基、乙氨基、丙基氨基、丁基氨基、己基氨基、苯氨基、苄基氨基、十六烷基氨基、及十八烷基氨基。
此外,更详细例示上述化学式1所示的二肽衍生物则如下:
2-(2-((t-丁氧羰基)氨基)-3-羟基丙烷酰胺基)-4-甲基戊酸甲酯;
2-(2-氨基-3-羟基丙烷酰胺基)-4-甲基戊酸甲酯;
2-(2-((t-丁氧羰基)氨基)-4-甲基戊烷酰胺基)乙酸甲酯;
2-(2-氨基-4-甲基戊烷酰胺基)乙酸甲酯;
2-(2-((t-丁氧羰基)氨基)-3-甲基丁烷酰胺基)乙酸甲酯;
2-(2-氨基-3-甲基丁烷酰胺基)乙酸甲酯;
2-(2-((t-丁氧羰基)氨基)-3-羟基丁烷酰胺基)-4-甲基戊酸甲酯;
2-(2-氨基-3-羟基丁烷酰胺基)-4-甲基戊酸甲酯;
2-(2-((t-丁氧羰基)氨基)-4-甲基戊烷酰胺基)丙酸乙酯;
2-(2-氨基-4-甲基戊烷酰胺基)丙酸乙酯;
2-(2-氨基-4-甲基戊烷酰胺基)丙酸;
2-(2-((t-丁氧羰基)氨基)-3-甲基丁烷酰胺基)丙酸甲酯;
2-(2-((t-丁氧羰基)氨基)-丙烷酰胺基)丙酸甲酯;
2-(2-((t-丁氧羰基)氨基)-乙烷酰胺基)丙酸甲酯;
2-(2-((t-丁氧羰基)氨基)-3-((4-羟苯基)丙烷酰胺基)丙酸甲酯;
2-(2-((t-丁氧羰基)氨基)-乙酰丙烷酰胺基)-3-(吲哚-3-基)丙酸甲酯;
2-(2-((t-丁氧羰基)氨基)-3-甲基丁烷酰胺基)-3-(吲哚-3-基)丙酸甲酯;
1-(2-((t-丁氧羰基)氨基)-3-苯基丙酰)吡咯烷-2-羧酸甲酯;
1-(2-((t-丁氧羰基)氨基)丙酰)吡咯烷-2-羧酸甲酯;
1-(2-((t-丁氧羰基)氨基)-3-甲基丁酰)吡咯烷-2-羧酸甲酯;
1-(2-((t-丁氧羰基)氨基)-4-甲基戊酰)吡咯烷-2-羧酸甲酯;
1-(5-氨基-2-((t-丁氧羰基)氨基)-5-氧代戊酰)吡咯烷-2-羧酸甲酯;
1-(2-((t-丁氧羰基)氨基)-3-羟基丁酰)吡咯烷-2-羧酸甲酯;
1-(4-t-丁氧基-2-((t-丁氧羰基)氨基)-4-氧代丁酰)吡咯烷-2-羧酸甲酯;
1-(4-氨基-2-((t-丁氧羰基)氨基)-4-氧代丁酰)吡咯烷-2-羧酸甲酯;
2-((2-甲氧羰基)吡咯烷-1-羰基)吡咯烷-1-羧酸t-丁酯;
1-((2,6-双(t-丁氧羰基)氨基)己酰)吡咯烷-2-羧酸甲酯;
1-(2-((t-丁氧羰基)氨基)-3-(咪唑-4-基)丙酰)吡咯烷-2-羧酸甲酯;
1-(5-t-丁氧基-2-((t-丁氧羰基)氨基)-5-氧代戊酰)吡咯烷-2-羧酸甲酯;
1-(2-((t-丁氧羰基)氨基)-3-(4-羟苯基)丙酰基)吡咯烷-2-羧酸甲酯;
1-(2-((t-丁氧羰基)氨基)-3-甲基戊酰)吡咯烷-2-羧酸甲酯;
1-(2-((t-丁氧羰基)氨基)乙酰基)吡咯烷-2-羧酸甲酯;
1-(2-((t-丁氧羰基)氨基)-3-羟基丙酰)吡咯烷-2-羧酸甲酯;
1-(2-((t-丁氧羰基)氨基)-4-甲硫基丁酰)吡咯烷-2-羧酸甲酯;
1-(2-((t-丁氧羰基)氨基)-3-(吲哚-3-基)丙酰)吡咯烷-2-羧酸甲酯;
1-(2-((t-丁氧羰基)氨基)-3-三苯甲硫基丙酰)吡咯烷-2-羧酸甲酯;
1-(2-((t-丁氧羰基)氨基)-3-巯基丙酰)吡咯烷-2-羧酸甲酯;
2-(2-((t-丁氧羰基)氨基)-4-甲基戊烷酰胺基))-3-羟基丁酸甲酯;
2-(2-((t-丁氧羰基)氨基)-3-甲基戊烷酰胺基))-丙酸乙酯;
2-(2-((t-丁氧羰基)氨基)-3-羟基丙烷酰胺基))-乙酸甲酯;
2-(2-((t-丁氧羰基)氨基)-乙烷酰胺基))-丙酸乙酯;
2-(2-((t-丁氧羰基)氨基)-4-甲基戊烷酰胺基))-3-苯基丙酸甲酯;
2-(2-((t-丁氧羰基)氨基)-乙烷酰胺基)-3-甲基丁酸甲酯;
2-(2-氨基-乙烷酰胺基)-3-甲基丁酸甲酯;
3-(1-(甲氧羰基)-2-苯基乙基氨甲酰)-3-氨基丙酸;
3-(1-甲氧羰基-2-苯基乙基氨甲酰)-3-(t-丁氧基羰基氨基)丙酸甲酯;
3-(1-(甲氧羰基)-2-苯基乙基氨甲酰)-3-氨基丙酸甲酯;
3-(1-(甲氧羰基)-2-苯基乙基氨甲酰)-3-(N-丁氧基羰基氨基)丙酸烯丙酯;
3-(1-(甲氧羰基)-2-苯基乙基氨甲酰)-3-氨基丙酸烯丙酯;
3-(1-(甲氧羰基)-2-苯基乙基氨甲酰)-3-(N-丁氧基羰基氨基)丙酸苄酯;
3-(1-(甲氧羰基)-2-苯基乙基氨甲酰)-3-氨基丙酸苄酯;
3-(1-(甲氧羰基)-2-苯基乙基氨甲酰)-3-(N-乙酰氨基)丙酸甲酯;
3-(1-(甲氧羰基)-2-苯基乙基氨甲酰)-3-(N-苯甲酰氨基)丙酸甲酯;
3-(1-(甲氧羰基)-2-苯基乙基氨甲酰)-3-(N-乙酰氨基)丙酸烯丙酯;
3-(1-(甲氧羰基)-2-苯基乙基氨甲酰)-3-(N-苯甲酰氨基)丙酸烯丙酯;
3-(1-(甲氧羰基)-2-苯基乙基氨甲酰)-3-(N-乙酰氨基)丙酸苄酯;
3-(1-(甲氧羰基)-2-苯基乙基氨甲酰)-3-(N-苯甲酰氨基)丙酸苄酯;
3-(1-(甲氧羰基)-2-苯基乙基氨甲酰)-3-(N-乙酰氨基)丙酸;
2-(2-乙酰氨基)-3-甲基丁烷酰胺基)乙酸甲酯;
2-(2-乙酰氨基)-4-甲基戊烷酰胺基)乙酸甲酯;
2-((2-吡咯烷氨甲酰)氨基)乙酸甲酯;
1-(2-氨基-3-(吲哚-3-基)丙酰基)吡咯烷-2-羧酸甲酯;
2-(2-氨基-3-甲基丁烷酰胺基)丙酸甲酯;
2-(2-氨基-3-甲基戊烷酰胺基)丙酸甲酯;以及
其农药学可接受的盐。
上述化学式1所示的二肽衍生物是用于合成2,5-哌嗪二酮化合物的中间体,及其制备方法已知于许多文献[Akiyama et al,J.Chem.Soc.,Perkin Trans.11989,235;Gordon et al,Bioorg.Med.Chem.Lett.,1995,5,47;Carlsson,A.C.TetrahedronLett.2006,47,5199;Lopez-Cobenas,A.Synlett.2005,1158;Boehm et al,J.Org.Chem.1986,51,2307;Thajudeen et al,Tetrahedron Lett.,2010,51,1303]。因此,有机合成领域技术人员可参照已知道的文献容易合成上述化学式1所示的二肽衍生物。
上述化学式1所示的二肽衍生物或其农药学可接受的盐可通过在植物中表达抗性基因,由此诱导植物疾病-预防蛋白产生,从而对各种由细菌,病毒和霉菌导致的植物疾病呈现抵抗效应。因此,其作为农业植物-保护剂的活性成分有用。具体而言,由细菌,病毒和霉菌导致的植物疾病可包括植物的细菌性软化病,猝倒病,疫霉枯萎病,萎缩病,叶斑病或花叶病。应用了包含上述化学式1所示的二肽衍生物作为活性成分的农业植物-保护剂的植物可为双子叶植物,例如,茄科(solanaceae)诸如马铃薯,辣椒,甜椒,及番茄,葫芦科(cucurbitaceae),诸如黄瓜,烟草,西瓜和东瓜,十字花科植物(十字花科(cruciferae))诸如白菜,莴苣,萝卜,卷心菜,油菜,花生,及芹菜,医药植物,诸如人参和当归,植物,诸如紫苏子,草莓,葱,大蒜,姜和洋葱,禾本科(graminae),诸如,稻,大麦,玉米和高粱,及果树,诸如苹果树,梨树,桃树和柿树。其可优选应用于双子叶植物,诸如,烟草,白菜,辣椒,草莓,黄瓜,马铃薯和番茄。
本发明的农业植物-保护剂可包含,作为活性成分,单独,上述化学式1所示的二肽衍生物或农药学可接受的盐。此外,本发明的农业植物-保护剂包含0.001~99wt%,及优选0.005~30wt%的活性成分,及可还另外包含赋形剂。赋形剂可为通用的微生物制剂,抗细菌剂效应-促进剂,稀释剂或载体。除了本发明的农业活性成分之外,为增加处理效应或扩大应用范围的目的而,还可以特定含量范围包含被常规商业化使用的,或开发的其他杀菌剂,杀昆虫剂,除草剂,植物生长-控制剂或肥料而配制成混合制剂类型。
本发明的农业植物-保护剂中包含的赋形剂及稀释剂是农业领域通常使用的,且可包括向其还添加固体载体,例如,氧化物,诸如,硅藻土和熟石灰,磷酸盐,诸如,磷灰石,硫酸盐,诸如,石膏和矿物质粉,诸如,粘土,高岭土,膨润土,酸粘土,石英和氧化硅,及填料,抗-聚集剂,表面活性剂,乳化剂,及防腐剂。此外,本发明的农业药物可通过使用本领域所知的方法配制成以迅速释放,持续释放及延迟释放的类型释放活性成分。为了制剂化,将通常使用的添加剂,诸如,表面活性剂,稀释剂,分散剂和佐剂与活性成分混合,然后,由此获得的混合物可配制为各种类型,诸如,水分散性粉剂,悬浮液,乳剂,可乳化的浓缩物,微乳剂,液体制剂,可分散制剂,颗粒水分散性粉剂,颗粒剂,粉末化药剂,液体水分散性粉剂,颗粒水分散性粉剂,浮水颗粒剂,及片剂而使用。
本发明的农业植物-保护剂可通过使用通用的方法应用于植物。对于将其应用于植物而言,其可直接喷或涂到植物体的叶,茎,枝,根和种子;可与通用的培养土壤,诸如,水稻田或旱田或苗圃床土壤或培养基混合;或,在水中培养的植物体的情况中,可处理到水的表面,以便预防疾病损伤。作为特定应用方法,可有涂敷处理,浸处理,熏蒸处理,或喷处理。例如,农业植物-保护剂可喷到土壤,或植物的叶,茎,种子,花或果实。为了向植物应用本发明的农业植物-保护剂,该剂可用水或适当的培养基稀释后使用。
为了确认植物疾病诱导性抗性(ISR)效应,植物生长-促进效应,及冷害-克服效应,实施多角度实验。
首先,用本发明的二肽衍生物处理辣椒植物,然后测量主要防御基因,例如,抗生素基因,诸如,PR-1,β-1,3-葡聚糖酶,几丁质酶,PR4,过氧化物酶和PR10引物的表达程度。确认,相比对照组,用上述化学式1所示的二肽衍生物处理的测试组中抑制植物疾病暴发的基因表达显著地增加。此外,也确认,防御基因在用植物病原体接种之前在仅用该剂处理时未表达,但在用植物病原体,诸如,细菌性软化病的病原体(胡萝卜软腐果胶杆菌(Pectobacterium carotovora)SCC1)和疫霉的病原体(辣椒疫霉(Phytophthoracapsici))感染的植物中抗性机理起动(见图1)。这便是所谓“增强作用(potentiation)”的现象。因此,可发现,本发明的农业植物-保护剂对抑制病原体的感染和繁殖具有优良效果,由此,预防或治疗植物疾病的暴发。用本发明的二肽衍生物处理结合了由PR-1α疾病抗性启动子诱导的GUS基因的烟草叶的结果,可确认,PR-1αGUS活性相比对照组显著地增加(见图2)。此外,为了确认通过用本发明的农业植物-保护剂处理植物来抑制植物疾病暴发的效应,以植物,诸如,烟草,白菜,黄瓜,辣椒和卷心菜作为对象,测试上述化学式1所示的二肽衍生物的溶液对抑制细菌性软化病或炭疽病的效应。可确认,当用上述化学式1所示的二肽衍生物处理植物时,其抑制植物疾病暴发的效应相比非-处理的组或对照药物(BTH)-处理的组显著地改善(见图3)。从观察通过用二肽衍生物处理种子,然后使种子生长而制备的植物叶上植物疾病暴发的阻遏程度的结果可确认,损伤形成相比非-处理的组大大地被抑制(见图4)。由此原因,可确认,当用本发明的二肽衍生物处理叶或茎时,抑制损伤的效应是优良的,及,甚至当用其处理种子时,也可抑制损伤形成。可确认,当将化合物89,91,93和107(本发明的二肽衍生物)直接喷到植物叶时,在用植物病原体感染植物之后,抑制辣椒疫霉枯萎病或细菌性软化病暴发的效应相比非-处理的对照组优良(见表7,及图5,7和9)。此外,可确认,当用化合物4,94,95和107(本发明的二肽化合物)浸透-处理植物的根时,叶上疫霉枯萎病的暴发显著地降低(见图6和8)。此外,当将本发明的二肽化合物喷到辣椒植物的叶,用辣椒疫霉(辣椒疫霉(Phytophthora capsici))感染植物的根,然后观察根和叶上的损伤形成时,叶和根上的损伤形成相比对照组显著地降低(见图10)。
此外,可确认,当用本发明的农业植物-保护剂处理植物时,植物生长促进相比非-处理的组达最大24.4%(见图6)。本发明的二肽化合物对防止植物冷害呈现优良效果,及当使得用二肽化合物浸透-处理或喷的叶在低温下暴露特定时间以使经历冷害时,叶呈现优良的克服冷害而恢复原状态的能力(见图11和12)。
如上所述,本发明的农业植物-保护剂可诱导植物疾病抗性;也可呈现促进生长的效应;及可呈现忍耐物理应激诸如冷害的效应。因此,本发明的剂在作为具有与常规植物-保护剂完全不同的作用机理的下一代农业植物-保护剂应用时具有非常高的价值。本发明的农业植物-保护剂的植物疾病-预防效应,植物生长-促进效应,及植物免疫-活化效应(植物疾病-抵抗效应和冷害-预防效应)会更详细描述于下列实施例。
如上所述,本发明会参照以下合成例和实施例更详细描述,但本发明不限于此。
【实施例】
【合成例】
【代表性的合成例:二肽衍生物的合成】
【(1)二肽合成方法A(化合物1,3,5,7,9,12~24,26,27,29,32~36,38~47,49,51~60,62~73,75,76,79~87,及106)】
将各种L-或D-型N-Boc-氨基酸(3.0mmol)溶于10mL的二甲基甲酰胺(DMF)。向其添加二异丙基甲基酰胺(DIEA;0.78g,6.0mmol),O-(苯并三唑-1-基)-N,N,N,N-四甲基脲鎓六氟磷酸盐(HBTU;1.37g,3.6mmol),然后搅拌约30分钟。将L-或D-型氨基酸烷基(甲基或乙基)酯(盐酸盐)(3.6mmol)加入由此获得的反应混合物,然后于室温搅拌12小时。将由此获得的反应混合物用乙酸乙酯稀释,然后用碳酸氢钠或盐水洗涤。用无水硫酸钠从有机层除去水,然后将无水有机层在减压下浓缩。将由此获得的浓缩的溶液通过氧化硅柱色谱仪(EtOAc/己烷)纯化而获得线性N-Boc-L-氨基酸-L-氨基酸烷基酯。缩合反应的收率是约50%~95%。
【(2)二肽合成方法B(化合物25,28,30,31,37,48,50,61,74,77,90,92和94)】
通过使用半胱氨酸的SH基被三苯甲基保护的半胱氨酸、末端COOH基转变为烷基酯的天冬氨酸或谷氨酸衍生物,及末端氨基被Boc或苄氧基羰基保护的赖氨酸或精氨酸10.0mmol、通过使用与以上描述的合成方法A相同的方法合成线性N-Boc-L-氨基酸-L-氨基酸烷基酯。缩合反应的收率是约65%~80%。
【(3)二肽合成方法C(化合物2,4,6,8,10,11,78,88,89,91,93,95和107~109)】
将由合成方法A和B获得的N-Boc-氨基酸-氨基酸烷基酯(5mmol)溶于50%三氟乙酸-二氯甲烷溶液(20mL),然后搅拌2小时。将溶剂在减压下蒸发而获得无保护基(诸如,Boc或三苯甲基)的氨基酸-氨基酸烷基酯三氟乙酸盐。作为另一方法,将N-Boc-氨基酸-氨基酸甲基酯(5mmol)溶于甲酸(10mL),搅拌6小时,然后真空-浓缩而获得无保护基的氨基酸-氨基酸烷基酯甲酸。化合物89购自Sigma-Aldrich而使用。化合物91,93和95可从上述合成方法得到,及也可从化合物89通过在MeCN/MeOH中分别与甲基碘,烯丙基溴和苄基氯反应而得到。
【(4)二肽合成方法D(化合物11)】
将由合成方法A和B获得的N-Boc-氨基酸-氨基酸烷基酯再次溶解于水溶性二噁烷,向其添加相当量的LiOH,然后将由此获得的混合物搅拌过夜。然后,将由此获得的混合物与乙酸中和,及用丙酮/乙醇的混合的溶剂萃取3次而获得无烷基的氨基酸-氨基酸。
【(5)二肽合成方法E(化合物96~105)】
将由合成方法C获得的氨基酸-氨基酸烷基酯盐(0.57mmol)溶于二氯甲烷(5mL),向其添加酰基氯(1.2eq)及三乙基胺(2.4eq),然后将由此获得的反应混合物于室温搅拌2小时。将由此获得的反应混合物添加到EtOAc(50mL),用1M HCl溶液,碳酸钠及饱和的盐水洗涤,然后浓缩。将由此获得的浓缩的溶液通过氧化硅柱色谱仪(EtOAc/己烷)纯化而以90%或更大的收率获得N-酰基氨基酸-氨基酸烷基酯。
将通过使用代表性的合成例的方法制备的化合物列于以下表1。
【表1】
【化合物1】
无色液体;1H NMR(400MHz,CD3OD)δ4.17(1H,t,J=4Hz),4.50(1H,dd,J=6.0,9.0Hz),3.75(2H,dd,J=11.2,5.2Hz),3.70(3H,s),1.63(1H,m),1.70-1.62(2H,m),1.45(9H,br s),0.93(3H,d,J=6.8Hz),0.92(3H,d,J=6.8Hz)。
【化合物2】
无色液体;1H NMR(400MHz,CD3OD)δ4.51(1H,m),4.50(1H,m),3.87(2H,d,J=11.2,5.2Hz),3.70(3H,s),1.66-1.63(2H,m),1.62(1H,m),0.95(3H,d,J=6.4Hz),0.92(3H,d,J=6.4Hz)。
【化合物3】
白色晶体;1H NMR(400MHz,CD3OD)δ4.12(1H,m),3.97(1H,d,J=17.6Hz),3.88(1H,d,J=17.6Hz),3.70(3H,s),1.71(2H,m),1.53(1H,m),1.44(9H,br s),0.95(3H,d,J=6.8Hz),0.93(3H,d,J=6.8Hz);13C NMR(100MHz,CD3OD)δ174.9,170.1,156.4,79.1,52.9,51.1,40.8,40.4,27.2,24.4,22.0,20.4。
【化合物4】
1H NMR(400MHz,CD3OD)δ4.07(2H,d,J=17.6Hz),3.90(1H,m),3.72(3H,s),1.63(1H,m),1.60-1.70(2H,m),0.93(3H,d,J=6.4Hz),0.90(3H,d,J=6.4Hz)。
【化合物5】
白色固体;1H NMR(400MHz,CD3OD)δ0.93(3H,d,J=6.8Hz),0.97(3H,d,J=7.2Hz),1.44(9H,br s),2.06(1H,m),3.67(3H,s),3.91(1H,m),3.97(2H,m);13C NMR(100MHz,CD3OD)δ173.6,170.0,156.5,79.1,59.9,51.1,40.3,30.6,27.2,18.2,16.8。
【化合物6】
白色固体;1H NMR(400MHz,CD3OD)δ1.06(3H,d,J=2.8Hz),1.08(3H,d,J=2.8Hz),2.20(1H,m),3.71(3H,s),3.74(1H,d,J=5.6Hz),3.93(1H,d,J=17.6Hz),4.09(1H,d,J=17.6Hz);13C NMR(100MHz,CD3OD)δ171.5,170.3,59.8,52.8,41.9,31.6,18.7,18.0。
【化合物7】
无色液体;1H NMR(400MHz,CD3OD)δ4.50(1H,dd,J=6.0,5.6Hz),4.05(1H,m),4.00(1H,m),3.69(3H,s),1.70(1H,m),1.68(1H,m),1.60(1H,m),1.44(9H,br s),1.19(3H,d,J=6.4Hz),0.94(3H,d,J=6.4Hz),0.91(3H,d,J=6.4Hz);3C NMR(100MHz,CD3OD)δ173.0,172.0,156.5,79.3,67.1,59.9,51.2,50.6,40.1,27.2,24.3,21.8,20.4,18.6。
【化合物8】
白色固体;1H NMR(400MHz,CD3OD)δ4.47(1H,dd,J=6.0,6.0Hz),4.35(1H,d,J=6Hz),4.10(1H,q.J=6Hz),3.70(3H,s),1.70(1H,m),1.68(1H,m),1.60(1H,m),1.21(3H,d,J=6.4Hz),0.95(3H,d,J=6.8Hz),0.90(3H,d,J=6.8Hz)。
【化合物9】
白色固体;1H NMR(400MHz,CD3OD)δ4.38(1H,q,J=7.6Hz),4.16(2H,q,J=7.2Hz),4.11(1H,t,J=4.4Hz),1.73(2H,m),1.52(1H,m),1.43(9H,br s),1.38(3H,d,J=7.2Hz),1.25(3H,t,J=7.2Hz),0.95(3H,d,J=6.8Hz),0.93(3H,d,J=6.8Hz)。
【化合物10】
白色固体;1H NMR(400MHz,CD3OD)δ4.38(1H,q,J=7.0Hz),4.16(2H,q,J=7.2Hz),3.36(1H,t,J=6.4Hz),1.73(2H,m),1.52(1H,m),1.38(3H,d,J=7.2Hz),1.25(3H,t,J=7.2Hz),0.96(3H,d,J=6.4Hz),0.93(3H,d,J=6.4Hz);13C NMR(100MHz,CD3OD)δ176.3,172.6,160.8,52.7,48.2,44.2,24.2,21.8,21.2,16.0,13.0。
【化合物11】
白色固体;1H NMR(400MHz,CD3OD)δ1.84(1H,m),1.61(1H,dd,J=8.4,5.6Hz),1.64(1H,dd,J=8.4,5.2Hz),3.93(1H,ddd,J=8.4,4.4,0.8Hz),3.99(1H,ddd,J=14.0,6.8,0.8Hz),1.44(3H,d,J=6.8Hz),0.96(3H,t,J=6.8Hz),0.96(3H,t,J=6.8Hz)。
【化合物12】
白色固体;1H NMR(CDCl3,400MHz)δ8.10(1H,s),7.96(1H,s),4.60(1H,q),4.52(1H,d),3.67(3H,s),2.66(1H,m),1.48(3H,s),1.40(9H,s),1.01(6H,d);13C NMR(CDCl3,100MHz)δ171.6,171.1,156.0,79.5,60.3,51.9,48.2,31.0,28.5,17.1。
【化合物13】
白色固体;1H NMR(CDCl3,400MHz)δ6.68(1H,s),5.12(1H,s),4.59-4.53(1H,m),4.17(1H,s),3.73(3H,s),1.43(9H,s),1.37-1.31(6H,m);13C NMR(CDCl3,100MHz)δ173.1,172.3,155.4,80.0,52.4,49.9,47.9,28.2,18.3,18.2。
【化合物14】
粘性液体;1H NMR(400MHz,CDCl3):δ6.50(1H,s),6.22(1H,s),4.74-4.69(1H,m),3.59(3H,s),3.49-3.47(2H,d),1.54(9H,s),1.29-1.27(3H,d);13C NMR(CDCl3,100MHz)δ171.6,170.7,156.3,79.5,51.9,47.9,45.0,28.5,17.2。
【化合物15】
粘性液体;1H NMR(400MHz,CDCl3)δ7.02(2H,d),6.74(2H,d),6.55(1H,d),5.11(1H,s),4.52(1H,t),4.29(1H,s),3.70(3H,s),2.97(2H,dd),1.41(9H,s),1.33(3H,d);13CNMR(CDCl3,100MHz)δ171.6,170.7,156.3,79.5,51.9,47.9,45.0,28.5,17.2。
【化合物16】
白色固体;1H NMR(CDCl3,400MHz)δ8.34(1H,s),7.50(1H,d),7.34(1H,d),7.19(1H,t),7.12(1H,t),6.97(1H,d),6.63(1H,d),5.11(1H,m),4.93(1H,m),3.73(2H,s),3.66(3H,s),3.31(2H,d),1.41(9H,s);13C NMR(CDCl3,100MHz)δ172.1,169.1,156.2,136.1,127.5,123.0,122.2,119.6,118.3,111.3,109.6,80.2,52.8,52.4,44.2,38.6,28.2,27.5。
【化合物17】
白色固体;1H NMR(DMSO-d6,400MHz)δ8.95(1H,s),7.50-7.48(1H,d),7.16-7.02(4H,m),6.72(1H,s),6.02(1H,s),4.88-4.84(1H,m),4.28-4.23(1H,m),3.54(3H,s),3.25-3.23(2H,d),1.55(9H,s),1.52-1.47(1H,m),1.01-0.99(6H,d);13C NMR(DMSO-d6,400MHz)δ175.8,171.2,152.5,135.9,128.5,122.8,120.7,119.6,118.1,112.2,109.3,79.9,55.6,51.9,37.8,28.7(3C),26.6,24.2(2C),21.4。
【化合物18】
粘性液体;1H NMR(CDCl3,400MHz)δ7.2(1H,s),5.29(1H,s),4.45(2H,d),3.85(2H,d),3.67(3H,s),1.45(9H,s);13C NMR(CDCl3,100MHz)δ171.5,171.0,155.5,80.3,51.2,48.5,46.1,29.0。
【化合物19】
1H NMR(CDCl3,400MHz)δ7.31-7.20(5H,m),5.24(1H,d),4.67(1H,dd),4.50(1H,dd),3.74(3H,s),3.61-3.57(1H,m),3.19-3.15(1H,m),3.11(1H,dd),2.93(1H,dd),2.17-2.13(1H,m),1.96-1.88(3H,m),1.37(9H,s);13C NMR(CDCl3,100MHz)δ172.5,170.8,155.3,136.5,129.9,128.5,126.9,79.8,60.6,59.1,53.4,52.4,47.0,39.4,29.2,28.5,25.0。
【化合物20】
粘性液体;1H NMR(CD3OD,400MHz)δ4.46(1H,dd,J=4.8,8.8Hz),4.37(1H,q,J=6.8Hz),3.77(1H,m),3.69(3H,s),3.65-3.62(1H,m),3.60-3.54(1H,m),2.30-2.23(1H,m),2.07-1.93(3H,m),1.42(9H,s),1.28(3H,d,J=7.6Hz);13C NMR(CDCl3,100MHz)δ172.7,172.6,156.2,79.0,58.9,51.3,47.7,46.6,28.5,27.3,24.5,15.7。
【化合物21】
1H NMR(CDCl3,400MHz)δ5.19(1H,d),4.52(1H,dd),4.28(1H,dd),3.77-3.73(1H,m),3.70(3H,s),3.64-3.62(1H,m),3.59-3.56(1H,m),2.23-2.19(1H,m),2.03-1.94(3H,m),1.40(9H,s),1.02(3H,d),0.92(3H,d);13C NMR(CDCl3,100MHz)δ172.6,171.4,156.0,79.6,58.9,57.0,52.3,47.3,31.5,29.2,28.5,25.2,19.4,17.5。
【化合物22】
1H NMR(CDCl3,400MHz)δ5.09(1H,d),4.45(1H,dd),4.39(1H,dd),3.71-3.68(1H,m),3.62(3H,s),3.53-3.51(1H,m),2.16-2.11(1H,m),2.01-1.86(3H,m),1.72-1.65(1H.m),1.42(1H,t),1.33(9H,s),0.92(3H,d),0.87(3H,d);13C NMR(CDCl3,100MHz)δ172.6,171.9,155.8,79.5,58.8,52.3,50.4,46.8,42.0,29.1,28.4,25.0,24.6,23.5,21.9。
【化合物23】
白色固体;1H NMR(CDCl3,400MHz)δ6.50(1H,s),5.95(1H,s),5.57(1H,d),4.47-4.42(2H,m),3.66-3.63(2H,t),3.64(3H,s),2.27-2.22(2H,m),2.16-2.04(2H,m),1.97-1.89(3H,m),1.81-1.77(1H,m),1.35(9H,s);13C NMR(CDCl3,100MHz)δ175.1,172.5,170.6,155.8,79.7,58.7,52.2,50.9,46.9,31.2,29.0,28.9,28.3,28.2,24.9。
【化合物24】
粘性液体;1H NMR(CDCl3,400MHz)δ5.48(1H,d),4.50(1H,dd),4.38(1H,dd),4.14(1H,m),3.76-3.74(1H,m),3.69(3H,s),3.47(1H,s),2.22-2.20(1H,m),2.01-1.93(3H,m),1.40(9H,s),1.19(3H,d);13C NMR(CDCl3,100MHz)δ172.5,170.9,156.1,79.9,67.4,58.8,55.7,52.7,52.4,47.2,38.5,31.3,28.9,24.8,18.5。
【化合物25】
粘性液体;1H NMR(CDCl3,400MHz)δ5.32(1H,d),4.81(1H,dd),4.46(1H,dd),3.73-3.69(2H,m),3.67(3H,s),2.65(1H,dd),2.45(1H,dd),2.17-2.12(1H,m),2.01-1.90(3H,m),1.39(9H,s),1.35(9H,s);13C NMR(CDCl3,100MHz)δ172.4,172.2,170.0,155.0,80.9,79.7,59.3,58.8,53.4,52.5,52.1,49.1,48.9,46.8,46.5,31.2,28.9,27.9,24.7。
【化合物26】
粘性液体;1H NMR(CDCl3,400MHz)δ6.85(1H,s),6.17(1H,d),6.02(1H,s),4.78(1H,dd),4.42(1H,dd),3.76-3.70(1H,m),3.61(3H,s),2.64-2.46(1H,m),2.17-2.12(1H,m),2.16-2.04(2H,m),1.99-1.89(3H,m),1.34(9H,s);13C NMR(CDCl3,100MHz)δ172.8,172.4,171.0,155.5,79.7,59.1,52.5,52.2,49.4,47.1,46.6,37.8,28.9,28.3,24.8。
【化合物27】
粘性液体;1H NMR(CDCl3,400MHz)δ4.50(1H,dd),4.43(1H,dd),3.69(3H,s),3.57-3.28(4H,m),2.12-1.73(8H,m),1.37(9H,s);13C NMR(CDCl3,100MHz)δ172.7,171.6,157.7,79.8,60.5,58.7,51.9,47.1,46.0,29.7,28.5,22.6,22.1。
【化合物28】
粘性液体;1H NMR(CDCl3,400MHz)δ5.30(1H,d),4.83(1H,s),4.54(1H,dd),4.46(1H,dd),3.72(3H,s),3.63-3.58(1H,m),3.13-3.08(2H,m),2.24-2.18(2H,m),2.07-1.93(3H,m),1.76-1.73(1H,m),1.60-1.37(5H,m),1.42(18H,s);13C NMR(CDCl3,100MHz)δ172.5,171.6,156.0,155.2,79.6,58.7,52.3,51.5,46.9,32.3,28.9,28.4,28.3,24.9,21.9。
【化合物29】
白色固体;1H NMR(CDCl3,400MHz)δ7.67(1H,s),7.42(1H,s),6.90(1H,s),5.59(1H,d),4.59(1H,dd),4.48(1H,dd),3.71(3H,s),3.62-3.58(1H,m),3.27-3.22(1H,m),3.10-2.97(2H,m),2.19(1H,dd),1.98-1.82(3H,m),1.35(9H,s);13C NMR(CDCl3,100MHz)δ173.4,170.6,155.2,135.2,127.9,122.5,79.9,59.0,52.6,51.9,47.0,29.5,28.9,28.8,28.3,28.2,25.1。
【化合物30】
白色固体;1H NMR(CDCl3,400MHz)δ5.34(1H,d),4.54-4.49(1H,m),4.39(1H,dd),3.69(3H,s),3.66-3.54(2H,m),2.34-2.18(2H,m),2.17-1.87(5H,m),1.76-1.67(1H,m),1.41(18H,s);13C NMR(CDCl3,100MHz)δ172.3,172.1,170.5,155.5,80.4,79.5,59.2,52.6,52.2,51.3,51.0,49.1,48.9,46.9,46.4,31.4,30.6,28.0,27.8,24.7。
【化合物31】
浅黄色固体;1H NMR(CDCl3,400MHz)δ9.38(1H,s),9.18(1H,s),7.29-7.16(10H,m),5.32(1H,d),5.14(2H,s),5.03(2H,s),4.38(1H,dd),4.34(1H,dd),3.92(2H,m),3.56-3.52(1H,m),3.50(3H,s),3.42-3.38(1H,m),2.67(2H,d),2.06-2.00(1H,m),1.82-1.74(2H,m),1.39-1.21(3H,m),1.31(9H,s);13C NMR(CDCl3,100MHz)δ172.1,170.8,165.5,163.7,160.5,160.4,155.7,155.7,155.4,137.0,134.8,128.6,128.6,128.3,127.9,127.8,127.8,127.6,79.3,68.7,66.8,58.7,51.9,51.5,46.7,44.3,38.5,29.7,28.8,28.3,24.8,24.5。
【化合物32】
白色固体;1H NMR(CDCl3,400MHz)δ7.57(1H,s),7.05(2H,d),6.70(2H,d),5.30(1H,d),4.61(1H,dd),4.49(1H,dd),3.68(3H,s),3.61-3.59(1H,m),3.28-3.26(1H,m),3.00(1H,dd),2.82(1H,dd),2.13-2.09(1H,m),1.95-1.88(3H,m),1.35(9H,s);13C NMR(CDCl3,100MHz)δ172.5,171.2,155.8,130.9,127.1,115.6,80.2,60.6,59.2,53.5,52.4,47.1,38.0,29.1,28.5,25.0,21.2,14.3。
【化合物33】
白色固体;1H NMR(CDCl3,400MHz)δ4.44(1H,dd),4.39(1H,dd),3.69(3H,s),3.61-3.33(4H,m),2.21-1.78(8H,m),1.43(9H,s);13C NMR(CDCl3,100MHz)δ173.2,172.6,153.9,79.9,59.5,58.0,52.3,52.0,47.1,46.0,30.0,29.4,28.4,24.5。
【化合物34】
白色固体;1H NMR(CDCl3,400MHz)δ5.16(1H,d),4.42(1H,dd),4.34(1H,dd),3.90-3.86(1H,m),3.70(3H,s),3.57-3.51(1H,m),2.20-2.17(1H,m),2.04-1.92(3H,m),1.71-1.66(1H,m),1.59-1.53(1H,m),1.41(9H,s),1.16-1.10(1H,m),0.91(3H,d),0.88(3H,t);13C NMR(CDCl3,100MHz)δ172.3,171.1,155.7,79.4,59.1,56.2,52.3,52.1,47.1,37.9,31.1,29.1,28.3,24.6,24.1,22.3,15.6,11.3,10.9。
【化合物35】
白色固体;1H NMR(CDCl3,400MHz)δ7.44(1H,s),7.00(2H,d),6.72(2H,d),5.43(1H,d),4.59(1H,dd),4.29(1H,dd),3.68(3H,s),3.55-3.49(1H,m),2.93(1H,dd),2.84(1H,dd),2.73-2.69(1H,m),2.13-2.09(1H,m),1.94-1.78(3H,m),1.36(9H,s);13C NMR(CDCl3,100MHz)δ172.3,170.7,155.66,130.4,127.8,115.4,80.0,60.5,59.4,58.8,53.7,52.6,46.9,39.2,38.6,31.1,28.3,24.4,21.2。
【化合物36】
粘性液体;1H NMR(CDCl3,400MHz)δ5.20(1H,d),4.48(1H,dd),4.38(1H,dd),3.85-3.80(1H,m),3.67(3H,s),3.54-3.43(2H,m),2.17-2.02(2H,m),1.98-1.91(2H,m),1.68-1.65(1H.m),1.41(1H,t),1.38(9H,s),0.94(3H,d),0.88(3H,d);13C NMR(CDCl3,100MHz)δ172.6,171.9,155.8,79.5,59.1,52.3,50.4,46.7,42.0,29.1,28.2,24.6,24.2,23.3,21.9。
【化合物37】
粘性液体;1H NMR(CDCl3,400MHz)δ5.22(1H,d),4.78(1H,dd),4.41(1H,dd),3.80-3.76(1H,m),3.67(3H,s),3.66-3.54(1H,m),2.73-2.67(1H,dd),2.50(1H,dd),2.19-2.14(1H,m),2.05-1.90(3H,m),1.35(18H,s);13C NMR(CDCl3,100MHz)δ172.3,169.7,169.5,154.9,80.9,79.8,59.1,59.0,52.6,52.0,49.3,48.9,46.9,46.6,31.0,29.0,28.2,27.9,24.8,22.4。
【化合物38】
粘性液体;1H NMR(CDCl3,400MHz)δ5.39(1H,s),4.50(1H,dd),3.94(1H,dd),3.69(3H,s),3.59-3.55(1H,m),3.46-3.40(1H,m),2.21-2.14(1H,m),2.10-1.94(4H,m),1.40(9H,s);13C NMR(CDCl3,100MHz)δ172.8,167.7,156.2,80.0,58.8,52.7,46.2,43.4,29.4,28.7,25.0。
【化合物39】
粘性液体;1H NMR(CDCl3,400MHz)δ5.66(1H,d),4.55(1H,dd),4.46(1H,dd),4.38(1H,m),3.81-3.77(1H,m),3.71(3H,s),3.67-3.49(2H,m),3.37(1H,s),2.26-2.20(1H,m),2.11-1.99(1H,m),2.01-1.91(2H,m),1.40(9H,s);13C NMR(CDCl3,100MHz)δ172.6,169.7,155.8,80.1,63.8,59.4,53.5,52.8,52.3,47.1,30.8,29.0,24.7,22.4。
【化合物40】
粘性液体;1H NMR(CDCl3,400MHz)δ5.33(1H,d),4.57(1H,dd),4.36(1H,dd),3.79-3.76(1H,m),3.64(3H,s),3.55-3.48(1H,m),2.50-2.42(2H,m),2.17-2.12(1H,m),2.01(3H,s),1.99-1.83(4H,m),1.80-1.70(1H,m),1.35(9H,s);13C NMR(CDCl3,100MHz)δ172.3,170.4,155.3,79.7,59.1,53.4,51.0,46.9,32.6,31.1,30.1,30.8,24.6,22.3,15.5。
【化合物41】
粘性液体;1H NMR(CDCl3,400MHz)δ5.52(1H,d),4.80(1H,dd),4.50(1H,dd),3.72(3H,s),3.67-3.62(1H,m),2.78(2H,t),2.28-2.20(1H,m),2.10-1.92(4H,m),1.81-1.77(1H,m),1.35(9H,s),0.86-0.81(1H,m);13C NMR(CDCl3,100MHz)δ172.3,172.1,167.3,154.7,80.8,59.3,53.0,52.4,48.8,47.2,46.8,38.6,29.0,28.2,24.7。
【化合物42】
粘性液体;1H NMR(CDCl3,400MHz)δ7.23-7.15(5H,m),5.38(1H,d),4.61(1H,dd),4.25(1H,dd),3.66(3H,s),3.49-3.45(1H,m),3.02(1H,dd),2.90(1H,dd),2.62-2.57(1H,m),1.92-1.75(3H,m),1.49-1.43(1H,m),1.37(9H,s);13C NMR(CDCl3,100MHz)δ172.3,170.2,154.9,136.4,129.4,128.3,126.8,79.6,58.6,53.5,52.5,46.7,40.3,28.9,28.3,24.3,22.4。
【化合物43】
白色固体;1H NMR(CDCl3,400MHz)δ8.45(1H,s),7.58(1H,d),7.32(1H,d),7.16(1H,t),7.09(1H,t),7.05(1H,d),5.52(1H,d),4.70-4.64(1H,m),4.15(1H,dd),3.67(3H,s),3.40-3.34(1H,m),3.27(1H,dd),3.15(1H,dd),2.47-2.41(1H,m),1.67-1.44(3H,m),1.44(9H,s),1.10-1.06(1H,m);13C NMR(CDCl3,100MHz)δ172.5,170.9,155.1,136.0,127.5,123.1,121.8,119.4,118.6,111.1,110.7,79.6,58.9,53.4,52.3,46.6,31.4,30.0,29.7,28.7,28.2,24.1。
【化合物44】
白色固体;1H NMR(CDCl3,400MHz)δ5.44(1H,d),4.48(1H,q),4.45(1H,dd),3.79-3.74(1H,m),3.69(3H,s),3.51-3.44(1H,m),2.20-2.16(1H,m),2.14-1.92(3H,m),1.38(9H,s),1.30(3H,d);13C NMR(CDCl3,100MHz)δ175.5,172.9,155.4,79.5,49.5,46.2,36.9,35.8,29.4,28.3,18.5。
【化合物45】
白色固体;1H NMR(CDCl3,400MHz)δ6.62(1H,s),5.82(1H,s),5.69(1H,d),4.45(1H,dd),4.40(1H,dd),3.69(3H,s),3.59-3.55(1H,m),2.31-2.16(5H,m),2.05-1.93(3H,m),1.79-1.75(1H,m),1.40(9H,s);13C NMR(CDCl3,100MHz)δ175.4,172.5,170.4,156.1,80.0,59.4,52.3,51.2,46.8,31.5,29.5,29.0,28.2,24.6,22.2。
【化合物46】
白色固体;1H NMR(CDCl3,400MHz)δ7.49(1H,s),7.42(1H,s),6.78(1H,s),5.63(1H,d),4.68(1H,dd),4.31(1H,dd),3.71(3H,s),3.63-3.49(2H,m),3.20-3.14(1H,m),2.95-2.86(1H,m),2.05-2.01(1H,m),1.98-1.70(3H,m),1.34(9H,s);13C NMR(CDCl3,100MHz)δ172.3,170.8,155.2,135.1,131.1,119.6,79.8,59.3,53.4,52.3,46.9,30.3,28.9,28.2,24.6,22.3。
【化合物47】
粘性液体;1H NMR(CDCl3,400MHz)δ5.50(1H,d),5.10(1H,dd),4.43(1H,dd),4.35(1H,dd),4.15(1H,q),3.83-3.78(1H,m),3.69(3H,s),3.66-3.64(1H,m),2.20-2.17(1H,m),2.04-1.92(3H,m),1.43(9H,s),1.15(3H,d);13C NMR(CDCl3,100MHz)δ172.5,171.0,156.1,80.0,67.5,59.0,55.1,54.0,52.7,52.3,47.2,38.6,30.7,29.0,24.8,18.7。
【化合物48】
粘性液体;1H NMR(CDCl3,400MHz)δ5.33(1H,d),4.88(1H,s),4.53(1H,dd),4.43(1H,dd),3.70(3H,s),3.61-3.59(1H,m),3.11-3.08(2H,m),2.21-2.14(2H,m),2.07-1.91(3H,m),1.76-1.72(1H,m),1.61-1.38(5H,m),1.40(18H,s);13C NMR(CDCl3,100MHz)δ172.4,171.1,156.0,155.5,79.5,78.8,58.6,52.2,51.5,46.8,40.1,32.2,29.3,28.9,28.4,28.3,24.9,21.9。
【化合物49】
粘性液体;1H NMR(CDCl3,400MHz)δ5.10(1H,d),4.22(1H,dd),4.12(1H,dd),3.72-3.764(1H,m),3.51(3H,s),3.41-3.33(1H,m),2.03-1.72(5H,m),1.24(9H,s),0.77(3H,d),0.72(3H,d);13C NMR(CDCl3,100MHz)δ172.2,170.7,155.5,79.0,58.7,56.7,51.9,46.9,31.1,28.9,28.1,24.5,19.5,19.4,17.2。
【化合物50】
粘性液体;1H NMR(CDCl3,400MHz)δ5.23(1H,d),4.50-4.48(2H,m),3.72-3.65(2H,m),3.68(3H,s),2.38-2.14(3H,m),2.09-1.88(4H,m),1.76-1.67(1H,m),1.42(18H,s);13CNMR(CDCl3,100MHz)δ172.2,172.1,170.8,155.5,80.4,79.5,59.7,52.1,50.9,46.8,30.7,28.9,28.3,28.0,27.7,24.9。
【化合物51】
白色固体;1H NMR(CDCl3,400MHz)δ5.44(1H,d),4.48(1H,q),4.45(1H,dd),3.79-3.74(1H,m),3.69(3H,s),3.50-3.44(1H,m),2.21-2.16(1H,m),2.12-1.92(3H,m),1.38(9H,s),1.29(3H,d);13C NMR(CDCl3,100MHz)δ172.6,171.8,155.2,79.6,59.0,52.5,47.9,46.8,29.0,28.3,24.6,22.4,18.7。
【化合物52】
白色固体;1H NMR(CDCl3,400MHz)δ8.68(1H,s),7.57(1H,d),7.32(1H,d),7.15(1H,t),7.08(1H,t),7.02(1H,d),5.54(1H,d),4.68-4.65(1H,m),4.14(1H,dd),3.65(3H,s),3.38-3.33(1H,m),3.26-3.21(1H,m),3.15(1H,dd),2.46-2.41(1H,m),1.65-1.51(3H,m),1.44(9H,s),1.10-1.06(1H,m);13C NMR(CDCl3,100MHz)δ172.5,170.9,155.1,136.0,127.5,123.2,121.8,111.2,79.6,58.9,53.4,52.1,46.6,38.6,30.0,28.7,24.1。
【化合物53】
浅黄色固体;1H NMR(CDCl3,400MHz)δ7.60(1H,s),6.99(2H,d),6.72(2H,d),5.43(1H,d),4.57(1H,dd),4.28(1H,dd),3.66(3H,s),3.52-3.50(1H,m),2.93(1H,dd),2.83(1H,dd),2.72-2.66(1H,m),1.96-1.76(3H,m),1.56-1.48(1H,m),1.40(9H,s);13C NMR(CDCl3,100MHz)δ172.6,170.7,155.6,130.4,127.7,115.4,80.0,58.9,53.4,52.6,52.3,46.9,39.2,28.9,28.2,24.4,22.3。
【化合物54】
白色固体;1H NMR(CDCl3,400MHz)δ6.65(1H,s),5.63(1H,dd),5.55(1H,s),4.49(1H,dd),4.41(1H,dd),3.71(3H,s),3.68-3.55(2H,m),2.35-2.14(3H,m),2.10-1.95(4H,m),1.79-1.71(1H,m),1.43(9H,s);13C NMR(CDCl3,100MHz)δ175.0,172.4,170.2,156.2,79.9,59.1,52.2,51.1,46.7,31.6,30.0,29.1,28.3,24.6,22.2。
【化合物55】
白色固体;1H NMR(CDCl3,400MHz)δ4.41(1H,dd),4.35(1H,dd),3.64(3H,s),3.59-3.29(4H,m),2.17-1.74(8H,m),1.39(9H,s);13C NMR(CDCl3,100MHz)δ173.1,172.4,154.4,79.8,59.1,58.0,52.0,46.5,46.4,31.5,29.8,28.9,28.4,24.9,23.2,22.5。
【化合物56】
粘性液体;1H NMR(CDCl3,400MHz)δ5.20(1H,d),4.38(1H,dd),4.29(1H,dd),3.87-3.81(1H,m),3.67(3H,s),3.54-3.48(1H,m),2.17-1.87(5H,m),1.39(9H,s),0.92(3H,d),0.87(3H,d);13C NMR(CDCl3,100MHz)δ172.4,170.9,155.7,79.3,58.8,56.8,52.3,47.0,31.3,29.1,28.3,24.6,19.6,17.3。
【化合物57】
粘性液体;1H NMR(CDCl3,400MHz)δ5.20(1H,d),4.47(1H,dd),4.37(1H,dd),3.84-3.81(1H,m),3.65(3H,s),3.53-3.44(2H,m),2.23-2.02(2H,m),1.98-1.91(2H,m),1.68-1.62(1H.m),1.41(1H,t),1.37(9H,s),0.94(3H,d),0.87(3H,d);13C NMR(CDCl3,100MHz)δ172.3,171.6,155.4,79.4,58.9,52.3,52.1,50.3,46.7,42.6,29.0,28.2,24.6,24.5,23.4,22.3,21.9。
【化合物58】
粘性液体;1H NMR(CDCl3,400MHz)δ5.15(1H,d),4.40(1H,dd),4.31(1H,dd),3.87-3.86(1H,m),3.67(3H,s),3.55-3.49(1H,m),2.20-1.92(4H,m),1.69-1.64(1H,m),1.55-1.49(1H,m),1.39(9H,s),1.12-1.04(1H,m),0.89(3H,d),0.86(3H,t);13C NMR(CDCl3,100MHz)δ172.3,171.1,155.7,79.4,58.8,56.2,52.2,52.1,47.1,37.8,31.1,29.1,28.3,24.6,24.0,15.6,11.2。
【化合物59】
粘性液体;1H NMR(CDCl3,400MHz)δ7.22-7.13(5H,m),5.38(1H,d),4.62(1H,dd),4.25(1H,dd),3.67(3H,s),3.52-3.46(1H,m),3.03(1H,dd),2.91(1H,dd),2.63-2.59(1H,m),1.92-1.75(3H,m),1.49-1.42(1H,m),1.39(9H,s);13C NMR(CDCl3,100MHz)δ172.3,170.2,154.9,136.4,129.4,128.3,126.5,79.6,59.2,53.6,52.5,46.7,40.3,28.9,28.3,28.2,24.4。
【化合物60】
粘性液体;1H NMR(CDCl3,400MHz)δ5.65(1H,d),4.56(1H,dd),4.46(1H,dd),3.79-3.52(4H,m),3.71(3H,s),3.35(1H,s),2.27-2.17(1H,m),2.09-1.93(3H,m),1.40(9H,s);13C NMR(CDCl3,100MHz)δ172.3,169.7,155.8,80.2,63.9,59.4,53.5,52.8,52.3,47.1,29.0,28.2,24.7,22.4。
【化合物61】
白色固体;1H NMR(CDCl3,400MHz)δ7.40(6H,d),7.28(6H,t),7.21(3H,t),5.22(1H,d),4.44(1H,dd),4.38(1H,dd),3.67(3H,s),3.61-3.56(1H,m),3.13-3.07(1H,m),2.59(1H,dd),2.42-2.34(1H,m),2.13-1.81(4H,m),1.42(9H,s);13C NMR(CDCl3,100MHz)δ172.2,169.1,154.9,144.5,129.6,127.9,126.7,79.7,66.8,59.0,52.2,51.3,46.8,34.5,29.0,28.3,24.6。
【化合物62】
粘性液体;1H NMR(CDCl3,400MHz)δ5.47(1H,d),4.45(1H,dd),4.33(1H,dd),4.09(1H,dd),3.81-3.50(3H,m),3.69(3H,s),2.25-2.17(1H,m),2.07-1.90(3H,m),1.40(9H,s),1.13(3H,d);13C NMR(CDCl3,100MHz)δ172.8,170.9,156.2,79.9,67.4,59.3,55.2,54.0,52.7,52.2,47.2,38.5,30.6,29.6,24.8,18.4。
【化合物63】
粘性液体;1H NMR(CDCl3,400MHz)δ5.29(1H,d),4.59(1H,dd),4.48(1H,dd),3.72-3.62(2H,m),3.65(3H,s),2.54(2H,t),2.19-2.14(1H,m),2.06(3H,s),2.02-1.88(4H,m),1.85-1.77(1H,m),1.36(9H,s);13C NMR(CDCl3,100MHz)δ172.2,170.7,155.4,79.6,58.7,53.4,50.8,46.9,38.5,32.4,31.1,29.7,28.9,24.8,22.1,15.5。
【化合物64】
白色固体;1H NMR(CDCl3,400MHz)δ5.56(1H,d),4.59-4.54(2H,m),3.87-3.84(1H,m),3.82-3.76(1H,m),3.72(3H,s),3.70-3.63(2H,m),3.35(1H,s),2.25-2.17(1H,m),2.03-1.92(3H,m),1.40(9H,s);13C NMR(CDCl3,100MHz)δ172.9,170.2,155.6,80.0,63.9,58.9,53.3,52.6,47.2,31.0,28.8,28.3,24.8,22.1。
【化合物65】
粘性液体;1H NMR(CDCl3,400MHz)δ7.28-7.17(5H,m),5.28(1H,d),4.64(1H,dd),4.47(1H,dd),3.70(3H,s),3.61-3.51(2H,m),3.18-3.12(1H,m),3.08(1H,dd),2.90(1H,dd),2.15-2.07(1H,m),1.94-1.83(3H,m),1.37(9H,s);13C NMR(CDCl3,100MHz)δ172.5,170.8,155.3,136.5,129.9,128.5,126.9,79.8,60.6,59.1,53.4,52.4,47.0,39.4,29.2,28.5,25.0。
【化合物66】
粘性液体;1H NMR(CDCl3,400MHz)δ4.56(1H,dd),4.47(1H,dd),3.67(3H,s),3.61-3.32(4H,m),2.20-1.72(8H,m),1.41(9H,s);13C NMR(CDCl3,100MHz)δ172.5,170.8,156.0,79.8,67.4,58.8,55.8,52.4,47.2,38.5,28.8,28.2,24.8,18.6。
【化合物67】
粘性液体;1H NMR(CDCl3,400MHz)δ5.54(1H,d),4.48(1H,dd),4.35(1H,dd),4.11-4.04(1H,m),3.69(3H,s),3.74-3.59(2H,m),3.57-3.49(1H,m),2.21-2.13(1H,m),2.02-1.88(3H,m),1.37(9H,s),1.17(3H,d);13C NMR(CDCl3,100MHz)δ172.5,170.8,156.0,79.8,67.4,58.8,55.8,52.4,47.2,38.5,28.8,28.2,24.8,18.6。
【化合物68】
粘性液体;1H NMR(CDCl3,400MHz)δ5.30(1H,d),4.54(1H,dd),4.45(1H,dd),3.72-3.60(2H,m),3.63(3H,s),2.51(2H,t),2.18-2.12(1H,m),2.03(3H,s),1.99-1.85(4H,m),1.82-1.73(1H,m),1.33(9H,s);13C NMR(CDCl3,100MHz)δ172.2,170.7,155.4,79.6,58.6,52.1,50.8,46.9,38.5,32.4,29.7,28.9,28.2,24.8,24.8,15.5。
【化合物69】
粘性液体;1H NMR(CDCl3,400MHz)δ5.13(1H,d),4.51(1H,dd),4.28(1H,dd),3.82-3.76(1H,m),3.69(3H,s),3.66-3.60(1H,m),2.22-2.16(1H,m),2.03-1.91(3H,m),1.75-1.70(1H,m),1.61-1.52(1H,m),1.39(9H,s),1.14-1.06(1H,m),0.99(3H,d),0.89(3H,t);13C NMR(CDCl3,100MHz)δ172.4,171.4,155.7,79.4,58.8,56.2,52.1,47.1,37.9,29.0,28.3,24.9,24.1,15.2,11.2。
【化合物70】
粘性液体;1H NMR(CDCl3,400MHz)δ5.33(1H,d),4.51(1H,dd),4.45(1H,t),3.69(3H,s),3.67-3.63(1H,m),3.60-3.54(1H,m),2.21-2.14(1H,m),2.07-1.88(3H,m),1.39(9H,s),1.33(3H,d);13C NMR(CDCl3,100MHz)δ172.4,171.7,155.2,79.5,58.6,52.2,47.7,46.7,28.9,28.3,24.9,18.2。
【化合物71】
粘性液体;1H NMR(CDCl3,400MHz)δ7.60(1H,s),7.06(2H,d),6.71(2H,d),5.31(1H,d),4.61(1H,dd),4.49(1H,dd),3.69(3H,s),3.62-3.58(1H,m),3.29-3.24(1H,m),3.00(1H,dd),2.82(1H,dd),2.16-2.10(1H,m),1.94-1.87(3H,m),1.36(9H,s);13C NMR(CDCl3,100MHz)δ172.3,171.0,155.8,130.7,127.0,115.4,79.9,59.1,53.3,52.2,46.9,38.6,37.9,28.9,28.3,24.8,22.2。
【化合物72】
粘性液体;1H NMR(CDCl3,400MHz)δ6.57(1H,s),5.95(1H,s),5.62(1H,d),4.49-4.42(2H,m),3.69(1H,m),3.68(3H,s),3.03(1H,s),2.31-2.26(2H,m),2.22-2.14(1H,m),2.11-1.78(5H,m),1.37(9H,s);13C NMR(CDCl3,100MHz)δ175.7,172.8,170.8,155.9,79.9,58.8,54.1,52.4,51.0,47.0,31.1,28.9,28.8,28.2,24.8。
【化合物73】
白色固体;1H NMR(CDCl3,400MHz)δ8.64(1H,s),7.67(1H,d),7.33(1H,d),7.15(1H,d),7.11(2H,t),5.35(1H,d),4.78(1H,dd),4.50(1H,dd),3.67(3H,s),3.55-3.49(1H,m),3.27-3.09(3H,m),2.14-2.06(1H,m),1.91-1.77(3H,m),1.38(9H,s);13C NMR(CDCl3,100MHz)δ172.6,171.2,155.4,136.1,127.8,123.8,121.7,119.3,118.5,111.2,109.7,79.6,58.8,58.7,52.4,52.1,46.8,38.6,29.0,28.5,28.3,24.8。
【化合物74】
白色固体;1H NMR(CDCl3,400MHz)δ7.43(6H,d),7.28(6H,t),7.21(3H,t),5.07(1H,d),4.43(1H,dd),4.32(1H,dd),3.61(3H,s),3.48-3.42(1H,m),3.12-3.06(1H,m),2.51(1H,d),2.15-2.05(1H,m),1.95-1.75(3H,m),1.56-1.48(1H,m),1.40(9H,s);13C NMR(CDCl3,100MHz)δ172.0,169.5,155.2,144.5,129.7,127.9,126.7,79.8,66.9,59.1,52.1,51.6,46.6,34.1,28.9,28.3,24.7。
【化合物75】
粘性液体;1H NMR(CDCl3,400MHz)δ5.13(1H,d),4.49(1H,dd),4.44(1H,t),3.76-3.70(1H,m),3.66(3H,s),3.58-3.53(1H,m),2.21-2.08(1H,m),2.05-1.89(3H,m),1.75-1.69(1H,m),1.46(2H,t),1.37(9H,s),0.95(3H,d),0.91(3H,d);13C NMR(CDCl3,100MHz)δ172.4,171.8,155.7,79.4,58.6,52.1,50.3,46.7,41.8,28.9,28.3,24.8,24.5,23.3,21.7。
【化合物76】
粘性液体;1H NMR(CDCl3,400MHz)δ5.19(1H,d),4.48(1H,dd),4.24(1H,dd),3.76-3.70(1H,m),3.66(3H,s),3.63-3.57(1H,m),2.21-2.13(1H,m),2.02-1.88(4H,m),1.37(9H,s),0.98(3H,d),0.89(3H,d);13C NMR(CDCl3,100MHz)δ172.4,171.1,155.8,79.3,58.7,56.8,52.0,47.0,31.2,28.9,28.3,24.9,19.2,17.3。
【化合物77】
白色固体;1H NMR(400MHz,CD3OD)δ7.20-7.42(15H,m),4.35(1H,dd,J=8.4,4.0Hz),4.10(1H,dd,J=9.2,5.2Hz),3.60(3H,s),3.31(1H,m),3.00(1H,m),2.48(1H,m),2.56(1H,m),2.15(1H,m),1.90(1H,m),1.88(2H,m),1.44(9H,br s)。
【化合物79】
粘性液体;1H-NMR(CD3OD,400MHz)δ4.45(1H,dd,J=5.6Hz和3.2Hz),4.30(1H,m),4.13(m,1H),3.73(3H,s),1.70(1H,m),1.53-1.58(2H,m),1.48(9H,br),1.17(3H,d,J=6.4Hz),0.96(3H,d,J=6.4Hz),0.94(3H,d,J=6.4Hz);13C NMR(CD3OD,100MHz)δ174.7,170.8,156.4,79.2,67.1,57.6,53.3,51.4,40.5,27.3,24.5,22.0,20.5,18.8。
【化合物80】
白色固体;1H NMR(CD3OD,400MHz)δ4.38(1H,q,J=6.8Hz),4.30(1H,m),4.14(1H,q,J=7.6Hz),3.92(1H,d,J=6.8Hz),1.75(1H,m),1.53(1H,m),1.43(9H,br),1.38(3H,d,J=6.8Hz),1.25(3H,t,J=7.2Hz),1.15(1H,m),0.95(3H,d,J=6.8Hz),0.90(3H,t,J=7.2Hz);13C NMR(CD3OD,100MHz)δ172.8,172.5,156.4,79.1,60.8,58.8,48.2,37.1,27.3,24.3,16.0,14.4,13.0,10.0。
【化合物81】
白色晶体固体;1H NMR(CD3OD,400MHz)δ4.17(1H,t,J=4.4Hz),3.95(2H,dd,J=17.2,4.4Hz),3.75(2H,d,J=5.2Hz),3.71(3H,s),1.45(9H,br);13C NMR(CD3OD,100MHz)δ172.3,170.3,156.3,79.4,61.9,56.5,51.3,40.5,27.3。
【化合物82】
粘性液体;1H NMR(CD3OD,400MHz)δ4.41(1H,q,J=6.8Hz),4.16(2H,q,J=7.6Hz),3.77(2H,dd,J=17.6,4.8Hz),1.44(9H,br),1.37(3H,d,J=7.2Hz),1.25(3H,t,J=6.8Hz);13C NMR(CD3OD,100MHz)δ172.7,170.8,156.9,79.2,60.9,48.2,42.9,27.3,16.2,13.0。
【化合物83】
白色晶体;1H-NMR(CD3OD,400MHz)δ7.18-7.28(5H,m),4.64(1H,t,J=6.4Hz),4.12(2H,q,J=6.8Hz),4.04(1H,m),3.15(1H,dd,J=14.4,8.0Hz),3.0(1H,dd,J=13.6,7.6Hz),1.62(1H,m),1.42(9H,br),1.38-1.36(2H,m),1.88(3H,t,J=7.6Hz),0.92(3H,t,J=6.4Hz),0.90(3H,t,J=6.4Hz);13C NMR(CD3OD,100MHz)δ174.0,171.3.8,156.2,136.5,128.9,128.0,126.4,79.1,60.9,53.6,53.0,40.8,37.0,27.3,24.4,21.9,20.6,13.0。
【化合物84】
白色固体;1H NMR(CD3OD,400MHz)δ7.61(1H,d,J=7.6Hz),7.35(1H,d,J=7.6Hz),7.33(1H,d),7.16(1H,s),7.11(2H,t,J=7.2Hz),4.50(1H,t,J=7.6Hz),4.41(1H,dd,J=8.0,3.2Hz),3.68(3H,s),3.15-3.20(1H,m),2.99-3.10(3H,m),2.19-2.16(1H,m),1.90-1.83(3H,m),1.37(9H,s);13C NMR(CD3OD,100MHz)δ172.6,172.1,156.2,136.5,127.4,123.7,121.2,120.9,118.5,110.9,108.9,79.1,59.1,58.8,52.8,51.7,45.9,29.6,28.5,27.2,24.3。
【化合物85】
粘性液体;1H NMR(CD3OD,400MHz)δ4.46(1H,dd,J=8.4,5.2Hz),4.20(1H,d,J=8.4Hz),3.90(1H,m),3.67(1H,m),3.69(3H,s),3.66-3.60(1H,m),2.27-2.22(1H,m),2.06-1.92(3H,m),1.78-1.73(1H,m),1.63-1.59(1H,m),1.42(9H,br),1.12-1.1.07(1H,m),0.99(3H,d,J=7.2Hz),0.89(3H,t,J=6.8Hz);13C NMR(CDCl3,100MHz)δ172.5,172.1,156.5,79.0,59.0,56.3,51.1,47.1,36.7,28.7,27.3,24.5,24.2,14.0,9.8。
【化合物86】
粘性液体;1H NMR(CD3OD,400MHz)δ4.46(1H,dd,J=4.8,8.8Hz),4.37(1H,q,J=6.8Hz),3.77(1H,m),3.69(3H,s),3.65-3.62(1H,m),3.60-3.54(1H,m),2.30-2.23(1H,m),2.07-1.93(3H,m),1.42(9H,s),1.28(3H,d,J=7.6Hz);13C NMR(CDCl3,100MHz)δ172.7,172.6,156.2,79.0,58.9,51.3,47.7,46.6,28.5,27.3,24.5,15.7。
【化合物87】
粘性液体;1H NMR(CD3OD,400MHz)δ4.36(1H,d,J=6.0Hz),3.73(2H,br),3.71(3H,s),2.18-2.10(1H,m),1.44(9H,s),0.94(3H,d,J=6.8Hz),0.93(3H,d,J=6.4Hz);13C NMR(CD3OD,100MHz)δ173.5,172.6,159.2,80.8,59.0,52.6,44.5,32.1,28.8,19.5,18.4。
【化合物88】
粘性液体;1H NMR(CD3OD,400MHz)δ4.36(1H,dd,J=5.6,2.8Hz),3.75(2H,br),3.72(3H,s),2.20-2.12(1H,m),0.96(3H,d,J=4.4Hz),0.94(3H,d,J=5.2Hz);13C NMR(CD3OD,100MHz)δ171.8,166.1,57.8,51.1,39.9,30.4,17.916.8。
【化合物90】
白色固体,mp 86~88℃;[α]D-13.6(c 1.0,CH3OH);1H NMR(CD3OD)δ7.27(2H,m),7.20(1H,m),7.18(2H,m),4.66(1H,dd,J=8.0,5.6Hz),4.45(1H,dd,J=7.6,6.0Hz),3.67(3H,s),3.66(3H,s),3.13(1H,dd,J=14.0,5.6Hz),3.02(1H,dd,J=14.0,8.0Hz),2.73(1H,dd,J=16.4,6.0Hz),2.59(1H,dd,J=16.4,7.6Hz),1.42(9H,s);13C NMR(CD3OD)δ171.8,171.6,171.1,156.1,136.4,128.9,128.1,126.5,79.5,53.7,51.3,51.0,48.2,36.9,35.8,27.2。
【化合物91】
粘性浅黄色液体;[α]D-3.73(c 0.54,CH3OH);1H NMR(CD3OD)δ8.24(1H,s),7.29(2H,m),7.23(1H,m),7.20(2H,m),4.71(1H,dd,J=8.4,5.6Hz),4.13(1H,dd,J=8.8,4.0Hz),3.74(3H,s),3.70(3H,s),3.20(1H,dd,J=14.0,5.6Hz),3.02(1H,dd,J=14.0,8.8Hz),2.96(1H,dd,J=14.0,4.0Hz),2.82(1H,dd,J=17.6,8.8Hz)ppm;13C NMR(CD3OD)δ173.1,171.8,169.9,166.8,138.0,130.3,129.8,128.2,55.7,53.1,53.0,51.0,38.2,36.6。
【化合物92】
白色固体;mp 88~91℃;[α]D-11.8(c 1.0,CH3OH);1H NMR(CD3OD)δ7.27(2H,m),7.20(1H,m),7.18(2H,m),5.92(1H,ddt,J=17.2,10.8,6.0Hz),5.30(1H,dq,J=17.2,1.2Hz),5.20(1H,dd,J=10.8,1.2Hz),4.66(1H,dd,J=7.6,5.2Hz),4.57(2H,brd,J=6.0Hz),4.47(1H,dd,J=8.0,5.2Hz),3.67(3H,s),3.13(1H,dd,J=13.2,5.2HZ),3.03(1H,dd,J=13.2,7.6Hz),2.77(1H,dd,J=16.4,5.2Hz),2.61(1H,dd,J=16.4,8.0Hz),1.42(9H,s)ppm;13C NMR(CD3OD)δ171.8,171.6,170.3,156.1,136.4,132.1,128.9,128.1,126.5,117.0,79.5,65.1,53.7,51.3,51.0,36.9,35.8,27.3。
【化合物93】
粘性液体;[α]D-4.063(c 0.58,CH3OH);1H NMR(CD3OD)δ8.24(1H,s),7.29(2H,m),7.22(1H,m),7.20(2H,m),5.94(1H,ddt,J=17.2,10.4,6.0Hz),5.34(1H,dq,J=17.2,1.2Hz),5.25(1H,dd,J=10.4,1.2Hz),4.71(1H,dd,J=8.4,5.6Hz),4.65(2H,brd,J=6.0Hz),4.14(1H,dd,J=8.8,4.0Hz),3.70(3H,s),3.20(1H,dd,J=14.0,5.6Hz),3.02(1H,dd,J=14.0,8.8Hz),2.99(1H,dd,J=14.0,4.0Hz),2.85(1H,dd,J=18.0,9.2Hz);13C NMR(CD3OD)δ173.1,171.1,169.8,166.8,138.0,133.3,130.3,129.8,128.2,119.2,67.3,55.7,53.0,50.9,38.2,36.7。
【化合物94】
白色固体;mp 55~60℃;[α]D-9.16(c 1.0,CH3OH);1H NMR(CD3OD)δ7.34(2H,m),7.27(2H,m),7.25(2H,m),7.21(1H,m),7.20(1H,m),7.18(2H,m),5.11(2H,s),4.66(1H,dd,J=8.0,5.6Hz),4.45(1H,dd,7.6,6.0Hz),3.67(3H,s),3.13(1H,dd,14.0,5.6Hz),3.02(1H,dd,14.0,8.0Hz),2.73(1H,dd,16.4,6.0Hz),2.59(1H,dd,16.4,7.6Hz),1.42(9H,s);13C NMR(CD3OD)δ171.8,171.6,170.4,156.1,136.4,135.9,128.9,128.1,128.1,127.8,126.5,126.5,79.5,66.2,53.7,51.3,51.0,36.9,35.8,27.2。
【化合物95】
粘性液体;1H NMR(CD3OD)δ8.18(s),7.36(2H,m),7.27(4H,m),7.25(3H,m),7.20(1H,m),7.20(2H,m),5.19(2H,d,J=2.8Hz),4.70(1H,dd,J=8.8,5.2HZ),4.19(1H,dd,J=8.8,4.0Hz),3.67(s),3.19(1H,dd,J=14.4,5.6Hz),2.98(1H,dd,J=14.0,8.8Hz),2.96(1H,dd,J=18.0,4.0Hz),2.90(1H,dd,J=18.0,8.8Hz);13C NMR(CD3OD)δ173.1,171.6,169.8,166.1,138.0,137.2,130.3,129.8,129.8,129.6,129.6,128.2,68.5,55.7,53.0,50.8,38.1,36.5。
【化合物96】
白色固体;1H NMR(CD3OD)δ7.32(2H,m),7.32(1H,m),7.32(2H,m),4.73(1H,dd,J=7.6,5.2Hz),4.53(1H,dd,J=8.0,6.4Hz),3.67(3H,s),3.65(3H,s),3.11(1H,dd,J=14.0,5.2Hz),3.01(1H,dd,J=14.0,7.6Hz),2.74(1H,dd,J=16.4,6.4Hz),2.55(1H,dd,J=16.4,8.0Hz),1.89(3H,s);13C-NMR(CD3OD)δ171.6,171.2,171.2,168.6,136.4,128.8,128.1,127.2,126.4,53.8,51.3,51.0,50.1,36.8,34.9,22.5。
【化合物97】
白色固体;1H NMR(CD3OD)δ7.79(2H,dd,J=6.8,1.6Hz),7.57(1H,tt,J=7.6,1.2Hz),7.47(2H,t,J=6.8,8.0),7.12(2H,m),7.12(1H,m),7.12(2H,m),4.99(1H,dd,J=7.6,5.2Hz),4.45(1H,dd,J=8.0,6.4Hz),3.67(3H,s),3.66(3H,s),3.14(1H,dd,J=14.0,5.2Hz),3.00(1H,dd,J=14.0,7.6Hz),2.94(1H,dd,J=16.4,6.4Hz),2.78(1H,dd,J=16.4,8.0Hz);13C NMR(CD3OD)δ171.6,171.2,171.2,168.6,136.4,133.4,131.6,128.8,128.1,128.1,127.2,126.4,53.8,51.3,51.0,50.1,36.8,34.9。
【化合物98】
白色固体;1H NMR(CD3OD)δ7.32(5H,m),5.92(1H,ddt,J=17.2,10.8,6.0Hz),5.30(1H,dq,J=17.2,1.2Hz),5.20(1H,dd,J=10.8,1.2Hz),4.80(1H,dd,J=7.6,5.2Hz),4.66(1H,dd,J=8.0,6.4Hz),4.57(2H,brd,J=6.0Hz),3.67(3H,s),3.14(1H,dd,J=14.0,5.2Hz),3.00(1H,dd,J=14.0,7.6Hz),2.83(1H,dd,J=14.0,5.2Hz),2.64(1H,dd,J=16.4,6.4Hz),1.89(3H,s);13C NMR(CD3OD)δ171.6,171.2,170.3,168.6,136.5,132.1,129.0,128.2,126.6,117.1,65.1,53.8,51.5,49.5,36.9,35.4,21.2。
【化合物99】
粘性液体;1H NMR(CD3OD)δ7.79(2H,dd,J=6.8,1.6Hz),7.57(1H,tt,J=7.6,1.2),7.47(2H,dd,J=6.8,8.0),7.11(5H,m),5.92(1H,ddt,J=17.2,10.8,6.0Hz),5.30(1H,dq,J=17.2,1.2Hz),5.20(1H,dd,J=10.8,1.2Hz),4.99(1H,dd,J=7.6,5.2Hz),4.68(1H,dd,J=8.0,6.4Hz),4.58(2H,brd,J=6.0Hz),3.70(3H,s),3.14(1H,dd,J=14.0,5.2Hz),3.01(1H,dd,J=14.0,7.6Hz),2.98(1H,dd,J=14.0,5.2Hz),2.81(1H,dd,J=16.4,6.4Hz);13C-NMR(CD3OD)δ171.6,171.2,170.4,168.6,136.4,134.0,133.4,131.6,128.8,128.1,128.1,127.2,126.4,119.0,65.1,53.8,51.3,51.0,36.8,35.0。
【化合物100】
白色固体;1H NMR(CD3OD)δ7.32(5H,m),7.21(5H,m),5.11(2H,s),4.78(1H,dd,J=7.6,5.2Hz),4.63(1H,dd,J=8.0,6.4Hz),3.67(3H,s),3.13(1H,dd,J=14.0,5.2Hz),3.00(1H,dd,J=14.0,7.6Hz),2.84(1H,dd,J=14.0,5.2Hz),2.65(1H,dd,J=16.4,6.4Hz),1.89(3H,s);13C NMR(CD3OD)δ171.8,171.6,171.2,170.2,168.6,136.5,135.9,128.9,128.1,128.1,127.9,127.8,126.5,66.1,53.8,51.3,49.6,36.8,35.4,21.0。
【化合物101】
白色固体;1H NMR(CD3OD)δ7.79(2H,dd,J=6.8,1.6Hz),7.57(1H,tt,J=7.6,1.2Hz),7.47(2H,dd,J=6.8,8.0Hz),7.34(2H,m),7.25(4H,m),7.20(1H,m),7.12(5H,m),5.13(2H,s),4.99(1H,dd,J=7.6,5.2Hz),4.45(dd,J=8.0,6.4Hz),3.69(s),3.14(dd,J=14.0,5.2Hz),3.00(dd,J=14.0,5.2Hz),2.94(dd,J=16.4,6.4Hz),2.78(dd,J=6.4,8.0Hz);13C NMR(CD3OD)δ171.6,171.2,170.5,168.6,136.3,135.9,133.4,131.6,128.8,128.1,128.1,128.1,127.9,127.8,127.2,126.4,66.3,53.8,51.3,50.1,36.8,35.2。
【化合物102】
白色固体;1H NMR(CD3OD)δ7.15(3H,m),7.04(2H,m),4.65(1H,dd,J=7.6,5.2Hz),3.79(1H,dd,J=8.0,6.4Hz),3.61(3H,s),3.11(1H,dd,J=14.0,5.2Hz),3.01(1H,dd,J=14.0,7.6Hz),2.74(1H,dd,J=16.4,6.4Hz),2.55(1H,dd,J=16.4,8.0Hz),1.89(3H,s);13C-NMR(CD3OD)δ173.1,171.6,171.1,170.7,135.8,129.1,128.4,126.9,53.5,52.2,49.1,37.4,35.3,22.4。
【化合物103】
白色固体;熔点180~190℃(癸);1H NMR(CDCl3,400MHz)δ7.23(1H,brt),6.65(1H,d,J=2.2Hz),4.39(1H,t,J=8.8Hz),4.08(1H,dd,J=18,6.0Hz)3.91(1H,dd,J=18,6.0Hz),3.72(3H,s),2.06(1H,m),2.0(3H,s),0.96(3H,d,J=7.6Hz),0.94(3H,d,J=7.6Hz)ppm;13C NMR(100MHz,CDCl3)δ172.2,170.6,170.2,58.5,52.5,41.3,31.3,23.2,19.3,18.5ppm。
【化合物104】
白色固体;1H NMR(CDCl3,400MHz)δ7.17(1H,brt),6.55(1H,d,J=8.4Hz),4.56(1H,m),4.03(1H,dd,J=18.4,6.0Hz)3.93(1H,dd,J=18.0,5.2Hz),3.72(3H,s),1.97(3H,s),1.66(2H,m),1.54(1H,m),0.92(3H,d,J=7.6Hz),0.90(3H,d,J=7.6Hz)ppm;13C NMR(100MHz,CDCl3)δ172.8,170.5,170.1,52.3,51.5,41.1,41.0,24.7,23.0,22.8,22.2ppm。
【化合物105】
白色固体;1H NMR(CDCl3,400MHz)δ7.57(1H,brt),4.60(1H,dd,J=7.2Hz),3.97(2H,d,J=6.0Hz),3.70(3H,s),3.55(1H,m),3.41(1H,m),2.43~2.38(1H.m),2.10(3H,s),2.01~1.93(2H,m),1.90~1.80(1H,m)ppm;13C NMR(100MHz,CDCl3)δ171.5,171.1,170.1,59.3,52.2,48.2,41.2,27.3,24.9,22.5ppm。
【化合物106】
粘性液体;1H NMR(CDCl3,400MHz)δ5.39(1H,s),4.50(1H,dd),3.94(1H,dd),3.69(3H,s),3.59-3.55(1H,m),3.46-3.40(1H,m),2.21-2.14(1H,m),2.10-1.94(4H,m),1.40(9H,s);13C NMR(CDCl3,100MHz)δ172.8,167.7,156.2,80.0,58.8,52.7,46.2,43.4,29.4,28.7,25.0。
【化合物107】
粘性液体;1H NMR(CD3OD,400MHz)δ7.52(1H,d,J=7.6Hz),7.33(1H,d,J=7.6Hz),7.10(1H,d),7.08(1H,s),7.01(2H,t,J=7.2Hz),4.80(1H,t,J=7.6Hz),4.20(1H,dd,J=8.0,3.2Hz),3.68(3H,s),3.39-3.26(1H,m),3.22-3.17(3H,m),2.38(H,m),2.03(3H,m);13CNMR(CD3OD,100MHz)δ173.6,169.9,138.2,128.7,124.7,122.7,120.0,119.7,112.6,110.6,61.0,60.9,55.4,53.0,47.6,31.2,28.5,25.0。
【化合物108】
粘性液体;1H NMR(CD3OD,400MHz)δ4.47(1H,q),3.70(3H,s),3.68(1H,d),2.21(1H,m),1.42(3H,s),1.09(6H,d);13C NMR(CD3OD,100MHz)δ174.2,169,5,59.7,52.9,49.7,31.7,18.8,18.0,17.3。
【化合物109】
白色固体;1H NMR(CD3OD,400MHz)δ4.90(1H,q,J=6.8Hz),4.84(1H,m),4.47(1H,q,J=7.6Hz),3.70(1H,d,J=6.8Hz),1.94(1H,m),1.61(1H,m),1.42(3H,d,J=6.8Hz),1.22(1H,m),1.07(3H,d,J=6.8Hz),0.99(3H,t,J=7.2Hz);13C NMR(CD3OD,100MHz)δ174.7,169.5,59.1,52.9,49.7,38.3,25.4,17.3,15.1,11.8。
【实施例1.辣椒植物中防御基因的表达】
为了证明在向辣椒接种处理本发明的二肽衍生物的情况中疾病抗性表达,使用PR-1,β-1,3-葡聚糖酶,几丁质酶,PR4,过氧化物酶和PR10引物,及辣椒幼苗。使辣椒的幼苗在温室中生长4周,向其以各种浓度喷化合物,然后,在3天或1周之后,分别接种疫霉(辣椒疫霉(Phytophthora capsici))及细菌性软化病的病原体(胡萝卜软腐果胶杆菌(Pectobacterium carotovora))。
然后,在12,24和48小时之后,收集1g量的相应辣椒叶,然后储存于-75℃的超低温室。将储存的植物叶随液氮粉碎,然后,通过使用RNA提取试剂盒(EASY-SPINTMIIP总RNA提取试剂盒,Intron Biotechnology,韩国)和由Kishimoto等人(2005)的Ex Taq聚合酶(TakaraBiomedicals,Otsu,日本)提取rRNA。为扩增,将0.1μg的cDNA,10pMol的各正向及反向引物,250nM的dNTP,及0.5U的Ex Taq聚合酶添加到20μL的缓冲溶液。于94℃和58℃在热循环仪(PTC-100,USA)中实施PCR,及在1%琼脂糖凝胶(在0.5×TAE缓冲剂中)(80V,60min)条件下分析由PCR产生的产物。全部RT-PCR测试重复两次。
由此获得的结果示于图1。根据图1可确认,当用化合物80或89处理,然后用胡萝卜软腐果胶杆菌(P.carotovora)或辣椒疫霉(P.capsici)处理时,PR1,PR4,PR10,β-1,3-葡聚糖酶,几丁质酶及过氧化物酶的基因强烈表达。
【实施例2.烟草叶上PR-1 Gus活化程度的测量】
在使结合了由PR-1α疾病-抗性启动子诱导的GUS基因的烟草(Xanth-nc)生长3周之后,将100μL的化合物74的稀释的溶液用注射器注射到第2个叶。在3天之后,对周围叶用穿孔器以5mm的内径尺寸收集,将由此获得的样品添加到1.5mL的微型离心管,及还添加20μL的GUS提取缓冲溶液而磨碎,然后以8000G离心3分钟,以获得上清液。添加相同的量的2mMMUG(4-甲基伞形花酰-B-葡萄糖醛酸苷)溶液,于37℃反应1小时,然后加入960μL的停止缓冲溶液(0.2M,Na2CO3溶液)而使成1mL。然后,用TKO 100荧光计(Hoefoer ScientificInstruments USA)测量荧光。此时,通过使用MU(4-甲基伞形酮)作为标准试剂校准荧光量,及通过使用MU-mM/样品-10mg/时间计算GUS活性。将由此获得的结果列于以下表2及显示于图2。
【表2】
自以上表2可确认,作为处理向烟草化合物74的情况中表达的GUS发色的结果,在以100ppm的浓度处理的情况中表达量最大。
【实施例3.对抑制植物疾病暴发的效应】
在向各种植物处理本发明的化合物之后,在以下方法中测量化合物对抑制植物疾病暴发的效应。
在直径10cm×高13cm的塑料盆中播种烟草或黄瓜,然后,将12个盆加入黄箱。在接种之后,将100μL接种到第1个叶开始出来的黄瓜或烟草的子叶。测试化合物将溶于20%甲醇~制造浓储物溶液,然后,将浓储物溶液稀释到1,10和100ppm的浓度。
在7天之后,将植物细菌性软化病的病原体(胡萝卜软腐果胶杆菌(Pectobacteriumcarotovora)SCC1)在TSA培养基中培养27小时;然后,向植物叶以108cfu/mL的浓度喷培养的病原体,及于30℃培养3天。将植物炭疽病菌(豆状毛盘孢(Colletotrichumorbiculare))在GBA(四季豆琼脂)培养基中培养,以诱导孢子约2~3周。以105细胞/mL的浓度喷菌,然后于26℃培养1天。当出来第4个或第5个叶时,向第3个叶接种200μL的各测试化合物。在7天之后,以108cfu/mL的浓度向植物叶喷植物细菌性软化病的病原体,然后于30℃培养3天。
肉眼实施调查,及根据细菌性软化病的软化程度研究0~100%的损伤相对面积。通过对叶上发生的损伤数进行计数来研究炭疽病。
对抑制对烟草植物的细菌性软化病的暴发的效应的测试结果示于图3的照片,及列于以下表3~6。
【表3】
【表4】
【表5】
【表6】
【实施例4.由种子处理对抑制黄瓜叶上疾病暴发的效应】
将化合物61或化合物74以100ppm的浓度沉积在黄瓜种子2小时,及在3周之后,以105孢子/mL的浓度向其喷炭疽病菌(豆状毛盘孢(Colletotrichum orbiculare))的孢子,然后,在7天之后,研究疾病发生。由此获得的结果示于图4的照片中。
根据图4可确认,相比非-处理的组,在用化合物61或化合物74处理的黄瓜叶上难以发现炭疽病。
以与实施例3相同的方法生长辣椒,然后,将测试化合物溶于20%甲醇,以制造浓储物溶液,及将浓储物稀释至0.1,1.0和10.0ppm的浓度。向叶喷或向叶浸透测试溶液。在7天之后,将植物细菌性软化病的病原体(胡萝卜软腐果胶杆菌(Pectobacteriumcarotovora)SCC1)在TSA培养基中培养27小时,然后,在8mm直径纸圆盘上,以108cfu/mL的浓度润湿。使纸圆盘位于切成圆形的叶的中心,然后,在约7天之后,测量损伤区。在疫霉的情况中,将培养疫霉(辣椒疫霉(Phytophthora capsici))的马铃薯琼脂培养基用穿孔器切成5mm内径尺寸,然后接种到叶上。在7天之后,观察损伤区。在细菌性软化病的情况中,当将化合物6,89,93和95喷射于辣椒叶时,相比非-处理的组,以1或10ppm的浓度未发现细菌性软化病。此外,为辣椒疫霉测试,当以1.0或10.0ppm的浓度浸透-处理化合物89,94,95和107和向叶喷射化合物107(1或0.1ppm)时,无损伤形成。尤其是,可确认,相比对照药物BTH,化合物89对阻遏辣椒疫霉枯萎病的发生呈现优良效果(见图7)。上述测试结果指示,这些化合物在植物中诱导疾病抗性,及抑制细菌性软化病或疫霉的病原体产生,由此提示,这些物质可用作农业杀菌剂。当向根浸透-处理这些化合物时,对叶上损伤形成的阻遏可被解释为,其由在全体植物中诱导系统性疾病抗性而得到。这些测试结果示于图5~9的照片。
【表7】
【实施例6.对抑制辣椒根中疫霉枯萎病的效应】
用与实施例3相同的方法生长辣椒,将化合物85喷到叶上,然后在1周之后,浸透-接种辣椒疫霉(Phytophthora capsici)游动孢子悬浮液。一边观察7天,一边研究叶和根上的损伤形成。与对照组相比,对于用化合物85处理的辣椒,显著地抑制叶和根上的疫霉枯萎病。化合物85抑制疫霉枯萎病的暴发的测试结果示于图10。
【实施例7.对促进植物生长的效应】
用活性成分(化合物5~8,14和15)浸透植物(辣椒,马铃薯,番茄,烟草,黄瓜和白菜)的叶,然后,在7天之后,测量植物长度。然后,接种植物疾病病原体,然后,在3~5天之后,测量植物叶的尺寸及与对照组比较而获得相对生长程度。将促进黄瓜叶生长的效应列于以下表8。
【表8】
从上述表8中所列的根据结果可确认,当用本发明的二肽衍生物处理时,促进黄瓜生长。因此,可确认,本发明的化合物诱导植物疾病-抗性,并也诱导植物生长-促进效应。也可认为,生长-促进能力是免于疾病的植物-保护能力的互补效能。
【实施例8.对克服辣椒植物上的冷害的效应】
为了确认本发明的化合物的免疫-活化效应,使植物暴露于可受人工冷害的温度,及观察生长和发育。在植物生长6周之后,将化合物浸透或喷到叶,和使植物生长1周。在使植物暴露在2℃生长室1天之后,使它们于室温生长3天。观察植物的生长和发育的程度及测定植物受冷害的程度。当用化合物95浸透-处理植物时,不受冷害。当喷到叶时,在用化合物90,91,93和95处理时也未观察到植物受冷害。由测试结果可确认,当应用化合物时,植物呈现疾病抗性和也诱导能甚至在物理有害环境(如冷害)下维持生长和发育的免疫-活化效应。测试结果示于图11和12的照片。
【制剂例】
制剂例是配制适宜于应用的包含上述化学式1所示的化合物作为活性成分的农业植物-保护剂的代表性的例。用于制剂而使用的组分的组成如下。
【制剂例1.水分散性粉剂】
将10g的化学式1的化合物,10g的NK250L(表面活性剂),10g的白炭墨,及70g的叶蜡石(填充剂)粉碎及混合而制备水分散性粉剂。
【制剂例2.乳剂】
将10g的化学式1的化合物,10g的DDY2000(表面活性剂),及80g的二甲苯混合而制备乳剂。
【制剂例3.液体水分散性粉剂】
将10g的化学式1的化合物,10g的HY1910(表面活性剂),5g的丙二醇,0.2g的黄原胶,0.15g的KM-73(消泡剂),0.2g的杀生物剂-LS(防腐剂),0.1g的KNP(粘度剂),及74.35g的水(填充剂)在球磨机中粉碎及混合而制备液体水分散性粉剂。
【制剂例4.浮水颗粒剂】
将5g的化学式1的化合物,7.5g的石蜡油,2g的烷基磺基琥珀酸钠(表面活性剂),3g的白炭墨,1.2g的黄原胶,0.8g的聚丙烯酸钠,及80.5g的氯化钾混合,用水平挤出机粒化,然后,干燥而制备浮水颗粒剂。
【制剂例5.颗粒剂】
将5g的化学式1的化合物,2.5g的HY1910(表面活性剂),0.2g的NK250L(表面活性剂),0.5g的苏打灰,2.0g的糊精,25g的膨润土,及64.8g的滑石与水混合而制造团,用水平挤出机粒化,然后,干燥而制备颗粒剂。
【制剂例6.混合的制剂】
在制剂例1~5中作为活性成分使用的化学式1的化合物在20wt%的范围之内,使用选自通用的杀菌剂,杀虫剂和除草剂的单物质或混合物来制备混合的制剂。
【工业实用性】
如上所述,在用本发明的农业植物-保护剂处理各种双子叶植物,诸如,辣椒,黄瓜,马铃薯和番茄的情况中,促进植物生长,及也呈现预防由细菌,病毒,或霉菌导致的植物疾病诸如细菌性软化病,猝倒病,疫霉枯萎病,萎缩病,叶斑病或花叶病的效应。即使其未直接应用于植物的损伤区,也呈现与上述相同的效应。此外,由于本发明的农业植物-保护剂呈现使植物不受低温损伤的预防冷害的效应,其呈现使植物健康生长的植物免疫-活化效应。
因此,本发明的农业植物-保护剂可应用于植物(详细,双子叶植物)而预防或抑制植物疾病,促进植物生长,或活化植物免疫。
Claims (8)
1.选自以下化学式1所示的二肽衍生物或其农药学可接受的盐的化合物作为活性成分用于制备预防植物疾病及活化植物免疫的农业植物-保护剂的用途:
[化学式1]
在以上化学式1中,
R1表示氢原子或t-丁氧羰基;
R2表示氢原子;
R3表示甲氧基羰基甲基、丙-2-烯氧基羰基甲基或苄氧基羰基甲基;
R4表示氢原子;
R5表示氢原子;
R6表示苄基;
R7表示氢原子;及
R8表示甲氧基。
2.权利要求1的用途,其中所述上述化学式1所示的二肽衍生物是外消旋混合物或异构化合物。
3.权利要求1的用途,其中所述上述化学式1所示的二肽衍生物是选自下列的化合物:
3-(1-甲氧羰基-2-苯基乙基氨甲酰)-3-(t-丁氧基羰基氨基)丙酸甲酯;
3-(1-(甲氧羰基)-2-苯基乙基氨甲酰)-3-氨基丙酸甲酯;
3-(1-(甲氧羰基)-2-苯基乙基氨甲酰)-3-氨基丙酸烯丙酯;
3-(1-(甲氧羰基)-2-苯基乙基氨甲酰)-3-氨基丙酸苄酯;以及
其农药学可接受的盐。
4.权利要求1的用途,其中所述农业植物-保护剂配制为选自下列的类型:水分散性粉剂,可乳化的浓缩物,液体制剂,可分散制剂,颗粒剂,粉末化药剂及片剂。
5.权利要求1的用途,其中所述农业植物-保护剂配制为选自下列的类型:悬浮液、颗粒水分散性粉剂、液体水分散性粉剂及浮水颗粒剂。
6.权利要求1的用途,其中所述植物疾病是细菌性软腐病,猝倒病,疫霉枯萎病,萎缩病,叶斑病或花叶病。
7.权利要求1的用途,其中所述植物是双子叶植物。
8.权利要求7的用途,其中所述双子叶植物选自:马铃薯,辣椒,甜椒,番茄,黄瓜,烟草,西瓜,香瓜,白菜,莴苣,萝卜,卷心菜,油菜,花生,芹菜,人参,当归,紫苏子,草莓,葱,大蒜,姜,洋葱,稻,大麦,玉米,高粱,苹果树,梨树,桃树和柿树。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20120040279 | 2012-04-18 | ||
KR10-2012-0040279 | 2012-04-18 | ||
PCT/KR2013/003303 WO2013157871A1 (ko) | 2012-04-18 | 2013-04-18 | 다이펩타이드 유도체를 활성 성분으로 함유하는 농업용 작물 보호제 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104363756A CN104363756A (zh) | 2015-02-18 |
CN104363756B true CN104363756B (zh) | 2017-10-31 |
Family
ID=49383749
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201380028197.3A Active CN104363756B (zh) | 2012-04-18 | 2013-04-18 | 含有二肽衍生物作为活性成分的农业植物‑保护剂 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20150119251A1 (zh) |
JP (1) | JP6219928B2 (zh) |
KR (1) | KR101352566B1 (zh) |
CN (1) | CN104363756B (zh) |
WO (1) | WO2013157871A1 (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101590255B1 (ko) | 2014-06-26 | 2016-01-29 | 주식회사 나프로바이오텍 | 미생물 Bacillus vallismortis BS07M 균주 발효액으로부터 제조된 고리형 다이펩타이드의 제조방법 |
KR101441986B1 (ko) | 2014-07-11 | 2014-09-24 | 주식회사 포이엔 | 농업용 약제 조성물 및 이의 제조방법 |
JP7059119B2 (ja) * | 2017-06-26 | 2022-04-25 | 三洋化成工業株式会社 | 植物成長促進剤 |
KR102493517B1 (ko) * | 2022-08-29 | 2023-01-31 | 김재현 | 냉해방지용 친환경 액상조성물 제조방법 및 냉해방지용 친환경 액상조성물 |
KR102629781B1 (ko) * | 2023-06-21 | 2024-01-25 | 임병성 | 냉해 및 동해 예방용 친환경 식물 영양제 제조방법 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4169141A (en) * | 1978-01-30 | 1979-09-25 | Shering Corporation | 1-Peptidyl derivatives of di-O-aminoglycosyl-1,3-diaminocyclitol antibacterial agents |
EP1028125A1 (en) * | 1998-11-30 | 2000-08-16 | Isagro Ricerca S.r.l. | Dipeptide compounds having fungicidal activity and their agronomic use |
KR20110120051A (ko) * | 2010-04-28 | 2011-11-03 | 공주대학교 산학협력단 | 2,5-다이케토피페라진 화합물의 제조방법 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4752602A (en) * | 1985-09-09 | 1988-06-21 | Board Of Regents, The University Of Texas System | Dipeptide alkyl esters and their uses |
JPS62240603A (ja) * | 1986-04-11 | 1987-10-21 | Teijin Ltd | 植物生長促進剤および植物生長促進法 |
JPS6372607A (ja) * | 1986-09-12 | 1988-04-02 | Teijin Ltd | 抗植物病害組成物および抗植物病害方法 |
IL107719A0 (en) * | 1992-12-21 | 1994-02-27 | Du Pont | Imidazolones their manufacture and their use as herbicides |
DK0662784T3 (da) * | 1993-08-03 | 2002-05-13 | Univ Iowa State Res Found Inc | Præemergent ukrudtsbekæmpelse ved anvendelse af naturlige herbicider |
IT1270882B (it) * | 1993-10-05 | 1997-05-13 | Isagro Srl | Oligopeptidi ad attivita' fungicida |
IT1271026B (it) * | 1994-10-21 | 1997-05-26 | Isagro Ricerca Srl | Derivati dell'acido b-amminopropionico ad attivita' fungicida |
KR20010041905A (ko) * | 1998-03-16 | 2001-05-25 | 시토비아 인크. | 디펩티드 카스파제 억제제 및 이의 용도 |
GB0005703D0 (en) * | 2000-03-09 | 2000-05-03 | Alpharma As | Compounds |
ITMI20040402A1 (it) * | 2004-03-03 | 2004-06-03 | Isagro Spa | Miscele e metodo per l'induzione di resistenza nella pianta |
US8815773B2 (en) * | 2009-07-29 | 2014-08-26 | Upl Limited | Herbicidal combination |
EP2594134B1 (en) * | 2010-07-15 | 2017-08-02 | Republic of Korea (Management: Rural Development Administration) | Use of an agricultural agent containing 2,5-diketopiperazine derivative as active ingredient |
-
2013
- 2013-04-18 KR KR20130042757A patent/KR101352566B1/ko active IP Right Grant
- 2013-04-18 CN CN201380028197.3A patent/CN104363756B/zh active Active
- 2013-04-18 WO PCT/KR2013/003303 patent/WO2013157871A1/ko active Application Filing
- 2013-04-18 JP JP2015506901A patent/JP6219928B2/ja active Active
- 2013-04-18 US US14/395,422 patent/US20150119251A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4169141A (en) * | 1978-01-30 | 1979-09-25 | Shering Corporation | 1-Peptidyl derivatives of di-O-aminoglycosyl-1,3-diaminocyclitol antibacterial agents |
EP1028125A1 (en) * | 1998-11-30 | 2000-08-16 | Isagro Ricerca S.r.l. | Dipeptide compounds having fungicidal activity and their agronomic use |
KR20110120051A (ko) * | 2010-04-28 | 2011-11-03 | 공주대학교 산학협력단 | 2,5-다이케토피페라진 화합물의 제조방법 |
Also Published As
Publication number | Publication date |
---|---|
WO2013157871A1 (ko) | 2013-10-24 |
JP6219928B2 (ja) | 2017-10-25 |
US20150119251A1 (en) | 2015-04-30 |
JP2015514753A (ja) | 2015-05-21 |
KR20130117720A (ko) | 2013-10-28 |
CN104363756A (zh) | 2015-02-18 |
KR101352566B1 (ko) | 2014-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104363756B (zh) | 含有二肽衍生物作为活性成分的农业植物‑保护剂 | |
JP6046617B2 (ja) | 2,5−ジケトピペラジン誘導体を活性成分として含む農業用薬剤 | |
CN108271339A (zh) | 栽培品种和物种间的种子内生菌、相关组合物及其使用方法 | |
AU2006303545B2 (en) | Compounds and relative use for the control of phytopathogens | |
CN103348984A (zh) | 一种氟醚菌酰胺复配杀菌剂 | |
ES2344259T3 (es) | Derivados fenilamidas siliconadas utiles como microbicidas. | |
JP5987672B2 (ja) | 植物病害防除剤及びそれを用いた植物病害の防除方法 | |
BR112017021537B1 (pt) | Agente de micro-organismo nematicida contra nematódeos parasíticos de planta, método para controle de nematódeos parasíticos de planta e método para preparação do dito agente | |
ES2199839T3 (es) | Composicion pesticida y procedimiento de lucha contra los parasitos. | |
Kalistratova et al. | Wheat (Triticum aestivum L.) reaction to new bifunctional carbamate compounds | |
ES2239272T3 (es) | Nuevos derivados fenil-propargileter. | |
CN101921244B (zh) | 含4-(1,1,2,2-四氟乙氧基)-3,5-二氯苯胺基的4-甲基-1,2,3-噻二唑的衍生物及其合成方法和用途 | |
EP3328201B1 (en) | Application of 7-carboxybenzo[1,2,3]thiadiazole amides as plant stimulants | |
WO2015152702A1 (es) | Extractos de cascarillas agrícolas efectivo para modificar el metabolismo de la plantas | |
CN110156685B (zh) | 芳香的环戊烯并吡啶及其合成方法和应用 | |
ES2346195T3 (es) | Nuevos derivados de fenetilamida de acido carboxilico alfa-oxigenados. | |
EA011548B1 (ru) | НОВЫЕ ПРОИЗВОДНЫЕ ФЕНЕТИЛАМИДОВ α-КАРБОНОВЫХ ИЛИ α-ТИОКАРБОНОВЫХ КИСЛОТ | |
CN107337633A (zh) | 含吡啶盐的戊二烯酮类化合物及其制备方法及应用 | |
BR112018007366B1 (pt) | Método para controlar uma doença de uma planta coffea, e, uso de lisina | |
UA73153C2 (en) | Pyrazolcarboxamide and pyrazolthioamide derivatives as a fungicides | |
CN102225931A (zh) | 含氨基酸酯的二效价顺式新烟碱类化合物及其制备方法和应用 | |
PL227421B1 (pl) | Zastosowanie arbutyny do poprawy kondycji roślin ogórka i ochrony przed chorobą bakteryjnej kanciastej plamistości | |
Arshad Javaid et al. | Effect of culture medium on herbicidal potential of metabolites of Trichoderma species against Parthenium hysterophorus. | |
FEDERATION | Gafurov Ravil'Gabdrakhmanovich (RU), Uchrezhdenie Rossijskoj Akademii nauk Institut fiziologicheski aktivnykh veshchestv RAN (IFAV RAN)(RU) | |
JP2013049631A (ja) | 植物ストレス軽減剤およびそれを用いた植物ストレス軽減法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |